메뉴 건너뛰기




Volumn 56, Issue 3, 1998, Pages 307-335

Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; ANTIINFECTIVE AGENT; CIMETIDINE; CLARITHROMYCIN; DIGOXIN; FAMOTIDINE; GASTRIN; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METRONIDAZOLE; MISOPROSTOL; NITROIMIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; TETRACYCLINE;

EID: 0031664974     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199856030-00002     Document Type: Review
Times cited : (240)

References (251)
  • 1
    • 0031470789 scopus 로고    scopus 로고
    • Structural aspects of the gastric H+, K+ ATPase
    • Shin JM, Besancon M, Bamberg K, et al. Structural aspects of the gastric H+, K+ ATPase. Ann N Y Acad Sci 1997; 834: 65-76
    • (1997) Ann N Y Acad Sci , vol.834 , pp. 65-76
    • Shin, J.M.1    Besancon, M.2    Bamberg, K.3
  • 3
    • 0030930189 scopus 로고    scopus 로고
    • Sites of reaction of the gastric H+, K+ ATPase with extracytoplasmic thiol reagents
    • Besancon M, Simon A, Sachs G, et al. Sites of reaction of the gastric H+, K+ ATPase with extracytoplasmic thiol reagents. J Biol Chem 1997; 272: 22438-46
    • (1997) J Biol Chem , vol.272 , pp. 22438-22446
    • Besancon, M.1    Simon, A.2    Sachs, G.3
  • 4
    • 0030774619 scopus 로고    scopus 로고
    • Lansoprazole: An update of its pharmacological properties and clinical efficacy in the management of acid related disorders
    • Langtry HD, Wilde MI. Lansoprazole: an update of its pharmacological properties and clinical efficacy in the management of acid related disorders. Drugs 1997; 54: 473-500
    • (1997) Drugs , vol.54 , pp. 473-500
    • Langtry, H.D.1    Wilde, M.I.2
  • 6
    • 0025856698 scopus 로고
    • Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione
    • Fujisaki H, Murakami M, Fujimoto M, et al. Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione. Biochem Pharm 1991; 42: 321-8
    • (1991) Biochem Pharm , vol.42 , pp. 321-328
    • Fujisaki, H.1    Murakami, M.2    Fujimoto, M.3
  • 7
  • 8
    • 0029877964 scopus 로고    scopus 로고
    • Wiseman. Pantoprazole: A review of its pharmacological properties and therapeutic use in acid-related disorders
    • Fitton A, Wiseman. Pantoprazole: a review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs 1996; 3: 460-82
    • (1996) Drugs , vol.3 , pp. 460-482
    • Fitton, A.1
  • 9
    • 0026415879 scopus 로고
    • Drug therapy: Omeprazole
    • Maton PN. Drug therapy: omeprazole. N Engl J Med 1991; 324: 965-75
    • (1991) N Engl J Med , vol.324 , pp. 965-975
    • Maton, P.N.1
  • 10
    • 0021881486 scopus 로고
    • Pharmacokinetics and metabolism of omeprazole in animals and man: An overview
    • Regardh C-G Gabrielsson M, Hoffman K-J, et al. Pharmacokinetics and metabolism of omeprazole in animals and man: an overview. Scand J Gastroenterol 1985; 20: 79-94
    • (1985) Scand J Gastroenterol , vol.20 , pp. 79-94
    • Regardh, C.-G.1    Gabrielsson, M.2    Hoffman, K.-J.3
  • 11
    • 0026276141 scopus 로고
    • The effect of food and antacids on lansoprazole absorption and disposition
    • Special edition No. III
    • Delhotal-Landes B, Cournot A, Vermerie N, et al. The effect of food and antacids on lansoprazole absorption and disposition. Eur J Drug Metab Pharmacokinet 1991 [Special edition No. III]: 315-20
    • (1991) Eur J Drug Metab Pharmacokinet , pp. 315-320
    • Delhotal-Landes, B.1    Cournot, A.2    Vermerie, N.3
  • 12
    • 0027231137 scopus 로고
    • Pharmacokinetics of pantoprazole following single intravenous and oral administration to healthy male subjects
    • Pue MA, Laroche J, Meineke I, et al. Pharmacokinetics of pantoprazole following single intravenous and oral administration to healthy male subjects. Eur J Clin Pharmacol 1993; 44 (6): 575-8
    • (1993) Eur J Clin Pharmacol , vol.44 , Issue.6 , pp. 575-578
    • Pue, M.A.1    Laroche, J.2    Meineke, I.3
  • 13
    • 0028074795 scopus 로고
    • Pharmacokinetic properties of E3810, a new proton pump inhibitor in healthy male volunteers
    • Yasuda S, Ohnishi A, Ogawa T, et al. Pharmacokinetic properties of E3810, a new proton pump inhibitor in healthy male volunteers. Int J Clin Pharm Ther 1994; 32: 466-73
    • (1994) Int J Clin Pharm Ther , vol.32 , pp. 466-473
    • Yasuda, S.1    Ohnishi, A.2    Ogawa, T.3
  • 14
    • 0021060508 scopus 로고
    • Dose response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release
    • Londong W, Londong V, Cederberg C, et al. Dose response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release. Gastroenterology 1983; 85 (6): 1373-8
    • (1983) Gastroenterology , vol.85 , Issue.6 , pp. 1373-1378
    • Londong, W.1    Londong, V.2    Cederberg, C.3
  • 15
    • 0021253872 scopus 로고
    • Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man
    • Howden CW, Forrest JAH, Reid JL. Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man. Gut 1984; 25 (7): 707-10
    • (1984) Gut , vol.25 , Issue.7 , pp. 707-710
    • Howden, C.W.1    Forrest, J.A.H.2    Reid, J.L.3
  • 16
    • 0347982184 scopus 로고
    • Single and repetitive administration of lansoprazole: Effects on gastric acid secretion pharmacokinetics and serum gastrin in old vs young subjects
    • Hogan DL, Koss MA, Freilelberg S, et al. Single and repetitive administration of lansoprazole: effects on gastric acid secretion pharmacokinetics and serum gastrin in old vs young subjects [abstract]. Gastroenterology 1991; 100: A84
    • (1991) Gastroenterology , vol.100
    • Hogan, D.L.1    Koss, M.A.2    Freilelberg, S.3
  • 17
    • 0024955966 scopus 로고
    • Human gastric acid secretion following repeated doses of AG-1749
    • Muller P, Dammann HG, Leucht U, et al. Human gastric acid secretion following repeated doses of AG-1749. Aliment Pharmacol Ther 1989; 3: 193-8
    • (1989) Aliment Pharmacol Ther , vol.3 , pp. 193-198
    • Muller, P.1    Dammann, H.G.2    Leucht, U.3
  • 18
    • 0026661433 scopus 로고
    • Effects of oral pantoprazole on 24 hour intra gastric acidity and plasma gastrin profiles
    • Hannan A, Weil J, Broom C. Effects of oral pantoprazole on 24 hour intra gastric acidity and plasma gastrin profiles. Aliment Pharmacol Ther 1992; 6 (3): 373-80
    • (1992) Aliment Pharmacol Ther , vol.6 , Issue.3 , pp. 373-380
    • Hannan, A.1    Weil, J.2    Broom, C.3
  • 19
    • 0002092519 scopus 로고    scopus 로고
    • The effects of rabeprazole on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects
    • Blanshard C, Millson C, Sercombe J, et al. The effects of rabeprazole on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects [abstract]. Gut 1996; 39: A47
    • (1996) Gut , vol.39
    • Blanshard, C.1    Millson, C.2    Sercombe, J.3
  • 20
    • 0001376589 scopus 로고    scopus 로고
    • A low dose of a new proton pump inhibitor LY-307640 (Ea3810) effectively inhibits acid secretion in humans
    • Kovacs TOG, Sytnik B, Humphries TJ, et al. A low dose of a new proton pump inhibitor LY-307640 (Ea3810) effectively inhibits acid secretion in humans [abstract]. Gastroenterology 1996; 110: A161
    • (1996) Gastroenterology , vol.110
    • Kovacs, T.O.G.1    Sytnik, B.2    Humphries, T.J.3
  • 21
    • 0028304317 scopus 로고
    • Comparison of lansoprazole with omeprazole on 24 hour intragastric pH acid secretion and serum gastrin in healthy volunteers
    • Des Varannes SB, Levy P, Lartigue S, et al. Comparison of lansoprazole with omeprazole on 24 hour intragastric pH acid secretion and serum gastrin in healthy volunteers. Aliment Pharmacol Ther 1994; 8 (3): 309-14
    • (1994) Aliment Pharmacol Ther , vol.8 , Issue.3 , pp. 309-314
    • Des Varannes, S.B.1    Levy, P.2    Lartigue, S.3
  • 22
    • 0031048267 scopus 로고    scopus 로고
    • 24 hour monitoring of intragastric acidity between lansoprazole 30 mg and pantoprazole 40 mg
    • Florent C, Forestier S. 24 hour monitoring of intragastric acidity between lansoprazole 30 mg and pantoprazole 40 mg. Eur J Gastroenterol Hepatol 1997; 9 (2): 195-200
    • (1997) Eur J Gastroenterol Hepatol , vol.9 , Issue.2 , pp. 195-200
    • Florent, C.1    Forestier, S.2
  • 23
    • 7344234508 scopus 로고
    • Effect of a new proton pump inhibitor on intragastric pH in the patients with peptic ulcer
    • Inoue M, Shirakawa, Murakami Y, et al. Effect of a new proton pump inhibitor on intragastric pH in the patients with peptic ulcer [abstract]. Gastroenterology 1991; 89: A100
    • (1991) Gastroenterology , vol.89
    • Inoue, M.1    Shirakawa2    Murakami, Y.3
  • 24
    • 0028799742 scopus 로고
    • Pathophysiological effects of long term acid suppression in man
    • McCloy RF, Arnold KD, Bardhan KD, et al. Pathophysiological effects of long term acid suppression in man. Dig Dis Sci 1995; 42 (Suppl.) 96S-120S
    • (1995) Dig Dis Sci , vol.42 , Issue.SUPPL.
    • McCloy, R.F.1    Arnold, K.D.2    Bardhan, K.D.3
  • 25
    • 0028298849 scopus 로고
    • Omeprazole: An update of its pharmacology and therapeutic use in acid-related disorders
    • Wilde MI, McTavish D. Omeprazole: an update of its pharmacology and therapeutic use in acid-related disorders. Drugs 1994; 48(1): 91-132
    • (1994) Drugs , vol.48 , Issue.1 , pp. 91-132
    • Wilde, M.I.1    McTavish, D.2
  • 26
    • 0028889189 scopus 로고
    • Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells
    • Freston JW, Borch K, Brand SJ, et al. Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. Dig Dis Sci 1995; 40 Suppl. 2: S50-S62
    • (1995) Dig Dis Sci , vol.40 , Issue.2 SUPPL.
    • Freston, J.W.1    Borch, K.2    Brand, S.J.3
  • 27
    • 7344237060 scopus 로고
    • Effect of lansoprazole on gastric acid secretion-inhibition of insulin stimulated acid secretion
    • Sugiyama M, Ishikawa T, Aoki T, et al. Effect of lansoprazole on gastric acid secretion-inhibition of insulin stimulated acid secretion. Shokakika 1991; 2: 183-93
    • (1991) Shokakika , vol.2 , pp. 183-193
    • Sugiyama, M.1    Ishikawa, T.2    Aoki, T.3
  • 28
    • 0028967475 scopus 로고
    • Pantoprazole versus omeprazole in the treatment of acute gastric ulcers
    • Witzel L, Gutz H, Huttemann W, et al. Pantoprazole versus omeprazole in the treatment of acute gastric ulcers. Aliment Pharm Ther 1995; 9: 19-24
    • (1995) Aliment Pharm Ther , vol.9 , pp. 19-24
    • Witzel, L.1    Gutz, H.2    Huttemann, W.3
  • 29
    • 0001684059 scopus 로고    scopus 로고
    • Rabeprazole sodium 20mg once daily is similar to omeprazole 20mg once daily in the healing of active duodenal ulcer
    • Beker JA, Dekkers CPM, Thjodleifsson B, et al. Rabeprazole sodium 20mg once daily is similar to omeprazole 20mg once daily in the healing of active duodenal ulcer [abstract]. Gastroenterology 1997; 112: A70
    • (1997) Gastroenterology , vol.112
    • Beker, J.A.1    Dekkers, C.P.M.2    Thjodleifsson, B.3
  • 30
    • 15844369552 scopus 로고    scopus 로고
    • Atrophic gastritis and H. pylori infection in patients with reflux oesophagitis treated with omeprazole or fundoplication
    • Kuipers EJ, Lundell L, Kilnkenberg-Knol EC, et al. Atrophic gastritis and H. pylori infection in patients with reflux oesophagitis treated with omeprazole or fundoplication. N Engl J Med 1996; 334: 1018-22
    • (1996) N Engl J Med , vol.334 , pp. 1018-1022
    • Kuipers, E.J.1    Lundell, L.2    Kilnkenberg-Knol, E.C.3
  • 31
    • 0029075476 scopus 로고
    • Long-term sequelae of helicobacter gastritis
    • Kuipers EJ, Vyterlinde AM, Pena AS, et al. Long-term sequelae of helicobacter gastritis. Lancet 1995; 345 (8964): 1525-8
    • (1995) Lancet , vol.345 , Issue.8964 , pp. 1525-1528
    • Kuipers, E.J.1    Vyterlinde, A.M.2    Pena, A.S.3
  • 32
    • 0030988041 scopus 로고    scopus 로고
    • Effects of gastrin on the histamine-secretory and proliferative activity of cultured carcinoid cells derived from the stomach of the rodent Mastomys natalensis
    • Takeno S, Daa T, Shimoda H, et al. Effects of gastrin on the histamine-secretory and proliferative activity of cultured carcinoid cells derived from the stomach of the rodent Mastomys natalensis. Pathol Int 1997; 47: 95-102
    • (1997) Pathol Int , vol.47 , pp. 95-102
    • Takeno, S.1    Daa, T.2    Shimoda, H.3
  • 33
    • 0026758709 scopus 로고
    • Hyperplasia of histaminc depleted enterochromaffin-like cells in rat stomach using omeprazole and alpha-flouoromethylhistidine
    • Andersson K, Hakanson R, Mattsson R, et al. Hyperplasia of histaminc depleted enterochromaffin-like cells in rat stomach using omeprazole and alpha-flouoromethylhistidine. Gastroenterology 1992; 103: 897-904
    • (1992) Gastroenterology , vol.103 , pp. 897-904
    • Andersson, K.1    Hakanson, R.2    Mattsson, R.3
  • 34
    • 0027200573 scopus 로고
    • Time-dependent changes in enterochromaffinlike cell kinetics in stomach of hypergastrinemic rats
    • Hakanson R, Tielemans Y, Chen D, et al. Time-dependent changes in enterochromaffinlike cell kinetics in stomach of hypergastrinemic rats. Gastroenterology 1993; 105: 15-21
    • (1993) Gastroenterology , vol.105 , pp. 15-21
    • Hakanson, R.1    Tielemans, Y.2    Chen, D.3
  • 35
    • 0026079050 scopus 로고
    • Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffin-like cell carcinoid in rats
    • Mattsson H, Havu N, Brautigam J, et al. Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffin-like cell carcinoid in rats. Gastroenterology 1991; 100: 311-9
    • (1991) Gastroenterology , vol.100 , pp. 311-319
    • Mattsson, H.1    Havu, N.2    Brautigam, J.3
  • 36
    • 0000715282 scopus 로고    scopus 로고
    • Gastritis development and acid suppression therapy revisited. Results of a randomized clinical study with long-term follow up
    • Lundell L, Havu N, Andersson A, et al. Gastritis development and acid suppression therapy revisited. Results of a randomized clinical study with long-term follow up [abstract]. Gastroenterology 1997; 112: A28
    • (1997) Gastroenterology , vol.112
    • Lundell, L.1    Havu, N.2    Andersson, A.3
  • 37
    • 0023789324 scopus 로고
    • Gastrin receptors in human gastric scirrhous carcinoma
    • Kumamoto T. Gastrin receptors in human gastric scirrhous carcinoma. Gastroenterol Jpn 1988; 23: 384-9
    • (1988) Gastroenterol Jpn , vol.23 , pp. 384-389
    • Kumamoto, T.1
  • 38
    • 0028043954 scopus 로고
    • Prognostic significance of gastrin receptors in human colorectal carcinoma
    • Turin
    • Scintu F, Oggianu A, Marongiu L, et al. Prognostic significance of gastrin receptors in human colorectal carcinoma. Chirurgia (Turin) 1994; 7: 605-9
    • (1994) Chirurgia , vol.7 , pp. 605-609
    • Scintu, F.1    Oggianu, A.2    Marongiu, L.3
  • 39
    • 0024581657 scopus 로고
    • Stereo selective interaction of omeprazole with warfarin in healthy men
    • Sutfin T, Balmer K, Bostrom H, et al. Stereo selective interaction of omeprazole with warfarin in healthy men. Ther Drug Monit 1989; 11: 176-84
    • (1989) Ther Drug Monit , vol.11 , pp. 176-184
    • Sutfin, T.1    Balmer, K.2    Bostrom, H.3
  • 40
    • 0026453659 scopus 로고
    • A study of the interaction of omeprazole and warfarin in anticoagulated patients
    • Unge P, Svedgerg LE, Nordgren A, et al. A study of the interaction of omeprazole and warfarin in anticoagulated patients. Br J Clin Pharmacol 1992; 34: 509-12
    • (1992) Br J Clin Pharmacol , vol.34 , pp. 509-512
    • Unge, P.1    Svedgerg, L.E.2    Nordgren, A.3
  • 41
    • 0025326803 scopus 로고
    • Effect of omeprazole and cimetidine on plasma diazepam levels
    • Anderson D, Andren K, Cederberg C, et al. Effect of omeprazole and cimetidine on plasma diazepam levels. Eur J Clin Pharmacol 1990; 39: 51-4
    • (1990) Eur J Clin Pharmacol , vol.39 , pp. 51-54
    • Anderson, D.1    Andren, K.2    Cederberg, C.3
  • 42
    • 0025340059 scopus 로고
    • A study of the interaction between omeprazole and phenytoin in epileptic patients
    • Anderson T, Lagerstrom PO, Unge P. A study of the interaction between omeprazole and phenytoin in epileptic patients. Ther Drug Monit 1990; 12: 329-33
    • (1990) Ther Drug Monit , vol.12 , pp. 329-333
    • Anderson, T.1    Lagerstrom, P.O.2    Unge, P.3
  • 44
    • 0000667890 scopus 로고    scopus 로고
    • Coadministration of rabeprazole sodium (E3810) and digoxin results in a predictable interaction
    • Humphries TJ, Spera AC, Laurent AL, et al. Coadministration of rabeprazole sodium (E3810) and digoxin results in a predictable interaction [abstract]. Am J Gastroenterol 1996; 91: 1914
    • (1996) Am J Gastroenterol , vol.91 , pp. 1914
    • Humphries, T.J.1    Spera, A.C.2    Laurent, A.L.3
  • 45
    • 0000667890 scopus 로고    scopus 로고
    • Rabeprazole sodium (E3810) 20mg daily does not affect the pharmacokinetics of phenytoin dosing in normal volunteers
    • Humphries TJ, Spera AC, Laurent AL, et al. Rabeprazole sodium (E3810) 20mg daily does not affect the pharmacokinetics of phenytoin dosing in normal volunteers [abstract]. Am J Gastroenterol 1996; 91: 1914
    • (1996) Am J Gastroenterol , vol.91 , pp. 1914
    • Humphries, T.J.1    Spera, A.C.2    Laurent, A.L.3
  • 46
    • 0002744577 scopus 로고    scopus 로고
    • Co-administration of rabeprazole sodium (E3810) does not effect the pharmacokinetics of anhydrous theophylline or warfarin
    • Humphries TJ, Nardi RV, Spara AC, et al. Co-administration of rabeprazole sodium (E3810) does not effect the pharmacokinetics of anhydrous theophylline or warfarin [abstract]. Gastroenterology 1996; 110: A138
    • (1996) Gastroenterology , vol.110
    • Humphries, T.J.1    Nardi, R.V.2    Spara, A.C.3
  • 47
    • 0002744577 scopus 로고    scopus 로고
    • Co-administration of rabeprazole sodium (E3810) and ketoconazole results in a predictable interaction with ketoconazole
    • Humphries TJ, Nardi RV, Spera AC, et al. Co-administration of rabeprazole sodium (E3810) and ketoconazole results in a predictable interaction with ketoconazole [abstract]. Gastroenterology 1996; 110: A138
    • (1996) Gastroenterology , vol.110
    • Humphries, T.J.1    Nardi, R.V.2    Spera, A.C.3
  • 48
    • 0025115304 scopus 로고
    • Omeprazole versus placebo in duodenal ulcer healing: The United States Experience
    • Graham DY, McCullough A, Sklar M, et al. Omeprazole versus placebo in duodenal ulcer healing: the United States Experience. Dig Dis Sci 1990; 35: 66-72
    • (1990) Dig Dis Sci , vol.35 , pp. 66-72
    • Graham, D.Y.1    McCullough, A.2    Sklar, M.3
  • 49
    • 0024892494 scopus 로고
    • Effect of 10mg and 20mg omeprazole daily on duodenal ulcer: Double-blind comparative trial
    • Lauritsen K, Andersen BN, Havelund T, et al. Effect of 10mg and 20mg omeprazole daily on duodenal ulcer: double-blind comparative trial. Aliment Pharmacol Ther 1989; 3: 59-67
    • (1989) Aliment Pharmacol Ther , vol.3 , pp. 59-67
    • Lauritsen, K.1    Andersen, B.N.2    Havelund, T.3
  • 50
    • 0022658435 scopus 로고
    • 20 versus 30mg omeprazole once daily: Effect on healing rates in 115 duodenal ulcer patients
    • Huttemann W, Rohner HG, DuBosque G, et al. 20 versus 30mg omeprazole once daily: effect on healing rates in 115 duodenal ulcer patients. Digestion 1986; 33: 117-20
    • (1986) Digestion , vol.33 , pp. 117-120
    • Huttemann, W.1    Rohner, H.G.2    DuBosque, G.3
  • 51
    • 0026480413 scopus 로고
    • Omeprazole 20 or 40mg daily for healing of duodenal ulcer: A double-blind comparative study
    • Laaritsen K, Rutgersson K, Bolling E. Omeprazole 20 or 40mg daily for healing of duodenal ulcer: a double-blind comparative study. Eur J Gastroenterol Hepatol 1992; 4: 995-1000
    • (1992) Eur J Gastroenterol Hepatol , vol.4 , pp. 995-1000
    • Laaritsen, K.1    Rutgersson, K.2    Bolling, E.3
  • 52
    • 0027535435 scopus 로고
    • Acute treatment of duodenal ulcer: Experience with lansoprazole
    • Mignon M, Vallot T. Acute treatment of duodenal ulcer: experience with lansoprazole. Aliment Pharmacol Ther 1993; 7: 37-40
    • (1993) Aliment Pharmacol Ther , vol.7 , pp. 37-40
    • Mignon, M.1    Vallot, T.2
  • 53
    • 0028223053 scopus 로고
    • Clinical effects of lansoprazole on patients with gastric and duodenal ulcer. Healing rate of S2 stage
    • Kitani M, Morisako K, Tanaka T, et al. Clinical effects of lansoprazole on patients with gastric and duodenal ulcer. Healing rate of S2 stage. Jpn Pharmacol Ther 1994; 22: 461-8
    • (1994) Jpn Pharmacol Ther , vol.22 , pp. 461-468
    • Kitani, M.1    Morisako, K.2    Tanaka, T.3
  • 54
    • 0025865672 scopus 로고
    • Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazole
    • Londong W, Barth H, Bammann HG, et al. Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazole. Aliment Pharmacol Ther 1991; 5: 245-54
    • (1991) Aliment Pharmacol Ther , vol.5 , pp. 245-254
    • Londong, W.1    Barth, H.2    Bammann, H.G.3
  • 55
    • 0028829243 scopus 로고
    • A comparison of three doses of lansoprazole (15, 30 and 60mg) and placebo in the treatment of duodenal ulcer
    • Avner DL, Dorsch ER, Jennings DE, et al. A comparison of three doses of lansoprazole (15, 30 and 60mg) and placebo in the treatment of duodenal ulcer. Aliment Pharmacol Ther 1995; 9: 521-8
    • (1995) Aliment Pharmacol Ther , vol.9 , pp. 521-528
    • Avner, D.L.1    Dorsch, E.R.2    Jennings, D.E.3
  • 56
    • 0026715568 scopus 로고
    • Dose-range finding study with the proton pump inhibitor pantoprazole in acute duodenal ulcer patients
    • Muller P, Simon B, Khalil H, et al. Dose-range finding study with the proton pump inhibitor pantoprazole in acute duodenal ulcer patients. Z Gastroenterol 1992; 30: 771-5
    • (1992) Z Gastroenterol , vol.30 , pp. 771-775
    • Muller, P.1    Simon, B.2    Khalil, H.3
  • 57
    • 0009675973 scopus 로고
    • LY 307640 versus placebo in healing duodenal ulcers
    • Cloud ML, Olovich K, Enas N, et al. LY 307640 versus placebo in healing duodenal ulcers [abstract]. Gastroenterology 1995; 108: A73
    • (1995) Gastroenterology , vol.108
    • Cloud, M.L.1    Olovich, K.2    Enas, N.3
  • 58
    • 0021969558 scopus 로고
    • Effect of omeprazole and cimetidine on duodenal ulcer: A double-blind comparative trial
    • Lauritsen K, Rune SJ, Bytzer P, et al. Effect of omeprazole and cimetidine on duodenal ulcer: a double-blind comparative trial. N Engl J Med 1985; 312: 958-61
    • (1985) N Engl J Med , vol.312 , pp. 958-961
    • Lauritsen, K.1    Rune, S.J.2    Bytzer, P.3
  • 59
    • 0023265269 scopus 로고
    • Omeprazole vs ranitidine in the short term treatment of duodenal ulcer: An Italian multicenter study
    • Barbara L, Blasi A, Cheli R, et al. Omeprazole vs ranitidine in the short term treatment of duodenal ulcer: an Italian multicenter study. Hepatogastroenterology 1987; 34: 229-32
    • (1987) Hepatogastroenterology , vol.34 , pp. 229-232
    • Barbara, L.1    Blasi, A.2    Cheli, R.3
  • 60
    • 0023920203 scopus 로고
    • Omeprazole (20mg daily) versus cimetidine (1200mg daily) in duodenal ulcer healing and pain relief
    • Archambault AP, Pare P, Bailey RJ, et al. Omeprazole (20mg daily) versus cimetidine (1200mg daily) in duodenal ulcer healing and pain relief. Gastroenterology 1988; 94: 1130-4
    • (1988) Gastroenterology , vol.94 , pp. 1130-1134
    • Archambault, A.P.1    Pare, P.2    Bailey, R.J.3
  • 61
    • 0025165075 scopus 로고
    • Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidine
    • McFarland RJ, Bateson MC, Green JRB, et al. Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidine. Gastroenterology 1990; 98: 278-83
    • (1990) Gastroenterology , vol.98 , pp. 278-283
    • McFarland, R.J.1    Bateson, M.C.2    Green, J.R.B.3
  • 62
    • 0025138675 scopus 로고
    • Omeprazole 20 mg o.m. vs. famotidine 40 mg h.s. in the treatment of duodenal ulcer. Multicenter double-blind randomized trial
    • Popovic O, Dzambas D, Tasic T, et al. Omeprazole 20 mg o.m. vs. famotidine 40 mg h.s. in the treatment of duodenal ulcer. Multicenter double-blind randomized trial. Gastroenterohepatoloski Arch 1990; 9: 26-34
    • (1990) Gastroenterohepatoloski Arch , vol.9 , pp. 26-34
    • Popovic, O.1    Dzambas, D.2    Tasic, T.3
  • 63
    • 0024935708 scopus 로고
    • Omeprazole and ranitidine in duodenal ulcer healing and subsequent relapse: A randomized double-blind study with weekly endoscopic assessment
    • Hui WM, Lau SK, Lau WY, et al. Omeprazole and ranitidine in duodenal ulcer healing and subsequent relapse: a randomized double-blind study with weekly endoscopic assessment. J Gastroenterol Hepatol 1989; 4: 35-43
    • (1989) J Gastroenterol Hepatol , vol.4 , pp. 35-43
    • Hui, W.M.1    Lau, S.K.2    Lau, W.Y.3
  • 64
    • 0024916069 scopus 로고
    • Symptom relief and duodenal ulcer healing with omeprazole or cimetidine
    • Crowe JP, Wilkinson SP, Bate CM, et al. Symptom relief and duodenal ulcer healing with omeprazole or cimetidine. Aliment Pharmacol Ther 1989; 3: 83-91
    • (1989) Aliment Pharmacol Ther , vol.3 , pp. 83-91
    • Crowe, J.P.1    Wilkinson, S.P.2    Bate, C.M.3
  • 65
    • 0025852038 scopus 로고
    • US experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine
    • Valenzuela JE, Berlin RG, Snape WJ, et al. US experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine. Dig Dis Sci 1991; 36: 761-8
    • (1991) Dig Dis Sci , vol.36 , pp. 761-768
    • Valenzuela, J.E.1    Berlin, R.G.2    Snape, W.J.3
  • 66
    • 0025740451 scopus 로고
    • The effect of omeprazole and ranitidine on ulcer healing, relief of symptoms and incidence of adverse effects in the treatment of duodenal ulcer patients
    • Kager L, Lindberg G, Nilsson LJ, et al. The effect of omeprazole and ranitidine on ulcer healing, relief of symptoms and incidence of adverse effects in the treatment of duodenal ulcer patients. Hepatogastroenterology 1991; 38: 287-90
    • (1991) Hepatogastroenterology , vol.38 , pp. 287-290
    • Kager, L.1    Lindberg, G.2    Nilsson, L.J.3
  • 67
    • 0025941847 scopus 로고
    • A Comparison of omeprazole and ranitidine for duodenal ulcer in South African patients: A multiracial study
    • Marks IN, Danilewitz MD, Garisch JAM. A Comparison of omeprazole and ranitidine for duodenal ulcer in South African patients: a multiracial study. Dig Dis Sci 1991; 36: 1395-400
    • (1991) Dig Dis Sci , vol.36 , pp. 1395-1400
    • Marks, I.N.1    Danilewitz, M.D.2    Garisch, J.A.M.3
  • 68
    • 0026699879 scopus 로고
    • Omeprazole versus famotidine in the short-term treatment of duodenal ulcer disease
    • Delle Fave G, Annibale B, Franceschi M, et al. Omeprazole versus famotidine in the short-term treatment of duodenal ulcer disease. Aliment Pharmacol Ther 1992; 6: 469-78
    • (1992) Aliment Pharmacol Ther , vol.6 , pp. 469-478
    • Delle Fave, G.1    Annibale, B.2    Franceschi, M.3
  • 69
    • 0027457040 scopus 로고
    • Treatment of duodenal ulcer with omeprazole or ranitidine in a Brazilian population: A multicenter double-blind, parallel group study
    • Zaterka S, Massuda H, Chinzon D, et al. Treatment of duodenal ulcer with omeprazole or ranitidine in a Brazilian population: a multicenter double-blind, parallel group study. Am J Gastroenterol 1993; 88: 397-401
    • (1993) Am J Gastroenterol , vol.88 , pp. 397-401
    • Zaterka, S.1    Massuda, H.2    Chinzon, D.3
  • 70
    • 0027514876 scopus 로고
    • Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine
    • Hawkey CJ, Long RG, Bardhan KD, et al. Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine. Gut 1993; 34: 1458-62
    • (1993) Gut , vol.34 , pp. 1458-1462
    • Hawkey, C.J.1    Long, R.G.2    Bardhan, K.D.3
  • 71
    • 0028074523 scopus 로고
    • Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer
    • Lanza F, Goff J, Scowcroft C, et al. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Am J Gastroenterol 1994; 89: 1191-200
    • (1994) Am J Gastroenterol , vol.89 , pp. 1191-1200
    • Lanza, F.1    Goff, J.2    Scowcroft, C.3
  • 72
    • 0028245586 scopus 로고
    • Comparison of pantoprazole and ranitidine in the treatment of acute duodenal ulcer
    • Judmaier G, Koelz HR, Brandstatter G, et al. Comparison of pantoprazole and ranitidine in the treatment of acute duodenal ulcer. Aliment Pharmacol Ther 1994; 8: 81-6
    • (1994) Aliment Pharmacol Ther , vol.8 , pp. 81-86
    • Judmaier, G.1    Koelz, H.R.2    Brandstatter, G.3
  • 73
    • 0028021923 scopus 로고
    • Improved duodenal ulcer healing with pantoprazole compared with ranitidine: A multicentre study
    • Van Rensburg CJ, Van Eeden PJ, Marks IN, et al. Improved duodenal ulcer healing with pantoprazole compared with ranitidine: a multicentre study. Eur J Gastrohepatol 1994; 6: 739-43
    • (1994) Eur J Gastrohepatol , vol.6 , pp. 739-743
    • Van Rensburg, C.J.1    Van Eeden, P.J.2    Marks, I.N.3
  • 74
    • 0029065815 scopus 로고
    • Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study
    • Schepp W, Classen M. Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study. Scand J Gastroenterol 1995; 30: 511-4
    • (1995) Scand J Gastroenterol , vol.30 , pp. 511-514
    • Schepp, W.1    Classen, M.2
  • 75
    • 6844256899 scopus 로고
    • Clinical utility of E3810 for the treatment of duodenal ulcer: Comparison with famotidine by multi-centre double blind study
    • Nakazawa S, Namiki M, Matsou Y, et al. Clinical utility of E3810 for the treatment of duodenal ulcer: comparison with famotidine by multi-centre double blind study. Rinsho Hyoka 1993; 21: 361-82
    • (1993) Rinsho Hyoka , vol.21 , pp. 361-382
    • Nakazawa, S.1    Namiki, M.2    Matsou, Y.3
  • 76
    • 0028989156 scopus 로고
    • 2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: A meta-analysis
    • 2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis. Eur J Gastroenterol Hepatol 1995; 7: 467-75
    • (1995) Eur J Gastroenterol Hepatol , vol.7 , pp. 467-475
    • Erikkson, S.1    Langstrom, G.2    Rikner, L.3
  • 77
    • 0029163151 scopus 로고
    • Meta-analysis of randomized clinical trials comparing lansoprazole, ranitidine or famotidine in the treatment of acute duodenal ulcer
    • Poynard T, Lemmaire M, Agostini H. Meta-analysis of randomized clinical trials comparing lansoprazole, ranitidine or famotidine in the treatment of acute duodenal ulcer. Eur J Gastroenterol Hepatol 1995; 7: 661-5
    • (1995) Eur J Gastroenterol Hepatol , vol.7 , pp. 661-665
    • Poynard, T.1    Lemmaire, M.2    Agostini, H.3
  • 78
    • 0001684058 scopus 로고    scopus 로고
    • Rabeprazole sodium once daily is superior to ranitidine 150 mg BID in the healing of active duodenal ulcer
    • Humphries TJ, Spera A, Breiter J, et al. Rabeprazole sodium once daily is superior to ranitidine 150 mg BID in the healing of active duodenal ulcer [abstract]. Gastroenterology 1997; 112: A154
    • (1997) Gastroenterology , vol.112
    • Humphries, T.J.1    Spera, A.2    Breiter, J.3
  • 79
    • 0028920093 scopus 로고
    • Lansoprazole versus omeprazole in active duodenal ulcer: A double-blind, randomized, comparative study
    • Ekstrom P, Carling L, Unge P, et al. Lansoprazole versus omeprazole in active duodenal ulcer: a double-blind, randomized, comparative study. Scand J Gastroenterol 1995; 30: 210-5
    • (1995) Scand J Gastroenterol , vol.30 , pp. 210-215
    • Ekstrom, P.1    Carling, L.2    Unge, P.3
  • 81
    • 0029038925 scopus 로고
    • Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer
    • Beker JA, Bianchi Porro G, Bigard MA, et al. Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer. Eur J Gastroenterol Hepatol 1995; 7: 407-10
    • (1995) Eur J Gastroenterol Hepatol , vol.7 , pp. 407-410
    • Beker, J.A.1    Bianchi Porro, G.2    Bigard, M.A.3
  • 82
    • 0029079685 scopus 로고
    • Comparison of pantoprazole versus omeprazole in the treatment of acute duodenal ulceration - A multicentre study
    • Rehner M, Rohner HG, Schepp W. Comparison of pantoprazole versus omeprazole in the treatment of acute duodenal ulceration - a multicentre study. Aliment Pharmacol Ther 1995; 9: 411-6
    • (1995) Aliment Pharmacol Ther , vol.9 , pp. 411-416
    • Rehner, M.1    Rohner, H.G.2    Schepp, W.3
  • 83
    • 0028235425 scopus 로고
    • Prevention of duodenal ulcer relapse by long-term treatment with omeprazole
    • Festen HPM. Prevention of duodenal ulcer relapse by long-term treatment with omeprazole. Scand J Gastroenterol 1994; 29 Suppl.: 39-41
    • (1994) Scand J Gastroenterol , vol.29 , Issue.SUPPL. , pp. 39-41
    • Festen, H.P.M.1
  • 84
    • 0028939088 scopus 로고
    • Prevention of duodenal ulcer relapse with omeprazole 20 mg daily: A randomized double-blind, placebo-controlled study
    • Goh KL, Boonyapisit S, Lai KH, et al. Prevention of duodenal ulcer relapse with omeprazole 20 mg daily: a randomized double-blind, placebo-controlled study. J Gastroenterol Hepatol 1995; 10: 92-7
    • (1995) J Gastroenterol Hepatol , vol.10 , pp. 92-97
    • Goh, K.L.1    Boonyapisit, S.2    Lai, K.H.3
  • 85
    • 0028090166 scopus 로고
    • Long term treatment with omeprazole 20mg three days a week or 10mg daily in the prevention of duodenal ulcer relapse
    • Bianchi Porro G, Corinaldesi R, Lazzaroni M, et al. Long term treatment with omeprazole 20mg three days a week or 10mg daily in the prevention of duodenal ulcer relapse. Aliment Pharmacol Ther 1994; 8: 541-8
    • (1994) Aliment Pharmacol Ther , vol.8 , pp. 541-548
    • Bianchi Porro, G.1    Corinaldesi, R.2    Lazzaroni, M.3
  • 86
    • 0029075374 scopus 로고
    • Six months of omeprazole 20 mg daily, 20mg every other day or 40mg at weekends in duodenal ulcer patients: A multicenter, prospective, comparative study
    • Olivieri P, Marcon V, Crestani B, et al. Six months of omeprazole 20 mg daily, 20mg every other day or 40mg at weekends in duodenal ulcer patients: a multicenter, prospective, comparative study. Digestion 1995; 56: 181-6
    • (1995) Digestion , vol.56 , pp. 181-186
    • Olivieri, P.1    Marcon, V.2    Crestani, B.3
  • 87
    • 9044243750 scopus 로고    scopus 로고
    • Omeprazole in the maintenance treatment of duodenal ulcer: Results after 6 months of 20mg daily, 20mg every other day, or 40mg on weekends
    • Di Mario F, Battaglia G, De Bonia M, et al. Omeprazole in the maintenance treatment of duodenal ulcer: results after 6 months of 20mg daily, 20mg every other day, or 40mg on weekends. Curr Ther Res - Clin Exp 1996; 57: 33-41
    • (1996) Curr Ther Res - Clin Exp , vol.57 , pp. 33-41
    • Di Mario, F.1    Battaglia, G.2    De Bonia, M.3
  • 88
    • 0029064626 scopus 로고
    • Lansoprazole for maintenance therapy of peptic ulcer disease, weekend full dose or everyday half dose administration?
    • Hoshino E, Umeda N, Sano J, et al. Lansoprazole for maintenance therapy of peptic ulcer disease, weekend full dose or everyday half dose administration? J Clin Gastroenterol 1995; 20 (S2): S72-S74
    • (1995) J Clin Gastroenterol , vol.20 , Issue.S2
    • Hoshino, E.1    Umeda, N.2    Sano, J.3
  • 89
    • 0031431559 scopus 로고    scopus 로고
    • Prevention of duodenal ulcer recurrence with 15mg lansoprazole. A double blind placebo controlled trial
    • Lanza F, Goff J, Silvers D, et al. Prevention of duodenal ulcer recurrence with 15mg lansoprazole. A double blind placebo controlled trial. Dig Dis Sci 1997; 42: 2529-36
    • (1997) Dig Dis Sci , vol.42 , pp. 2529-2536
    • Lanza, F.1    Goff, J.2    Silvers, D.3
  • 90
    • 0023765545 scopus 로고
    • Treatment of benign gastric ulcer with omeprazole 30 mg once daily
    • Farup PG, Darle N, Falk A, et al. Treatment of benign gastric ulcer with omeprazole 30 mg once daily. Curr Ther Res - Clin Exp 1988; 43: 872-7
    • (1988) Curr Ther Res - Clin Exp , vol.43 , pp. 872-877
    • Farup, P.G.1    Darle, N.2    Falk, A.3
  • 91
    • 0024906342 scopus 로고
    • Omeprazole 20 mg and 40 mg daily in the treatment of gastric ulcer: A pilot study in Filipino patients
    • Gloria VI, Domingo EO, Makalinao U, et al. Omeprazole 20 mg and 40 mg daily in the treatment of gastric ulcer: a pilot study in Filipino patients. J Gastroenterol Hepatol 1989; 4: 63-8
    • (1989) J Gastroenterol Hepatol , vol.4 , pp. 63-68
    • Gloria, V.I.1    Domingo, E.O.2    Makalinao, U.3
  • 92
    • 0029903385 scopus 로고    scopus 로고
    • Comparison of once-daily doses of omeprazole (40 and 20 mg) and placebo in the treatment of benign gastric ulcer: A multicenter, randomized, double-blind study
    • Valenzuela JE, Kogut DG, McCullough AJ, et al. Comparison of once-daily doses of omeprazole (40 and 20 mg) and placebo in the treatment of benign gastric ulcer: a multicenter, randomized, double-blind study. Am J Gastroenterol 1996; 91: 2516-22
    • (1996) Am J Gastroenterol , vol.91 , pp. 2516-2522
    • Valenzuela, J.E.1    Kogut, D.G.2    McCullough, A.J.3
  • 93
    • 0029162268 scopus 로고
    • Comparison of once daily doses of lansoprazole (15, 30 and 60 mg) and placebo in patients with gastric ulcer
    • Avner DL, Movva R, Nelson KJ, et al. Comparison of once daily doses of lansoprazole (15, 30 and 60 mg) and placebo in patients with gastric ulcer. Am J Gastroenterol 1995; 90: 1289-94
    • (1995) Am J Gastroenterol , vol.90 , pp. 1289-1294
    • Avner, D.L.1    Movva, R.2    Nelson, K.J.3
  • 95
    • 0002744577 scopus 로고    scopus 로고
    • Rabeprazole (E3810, LY307640) achieves high rates of healing in active gastric ulcer
    • Humphries TJ, Cloud ML, Enas N, et al. Rabeprazole (E3810, LY307640) achieves high rates of healing in active gastric ulcer [abstract]. Gastroenterology 1996; 110: A138
    • (1996) Gastroenterology , vol.110
    • Humphries, T.J.1    Cloud, M.L.2    Enas, N.3
  • 96
    • 0024552757 scopus 로고
    • Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer
    • Walan A, Bader JP, Classen M, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 1989; 320: 69-75
    • (1989) N Engl J Med , vol.320 , pp. 69-75
    • Walan, A.1    Bader, J.P.2    Classen, M.3
  • 97
    • 0026037164 scopus 로고
    • Omeprazole 20 mg od and ranitidine 150 mg bid in the treatment of benign gastric ulcer
    • Cisternino M. Omeprazole 20 mg od and ranitidine 150 mg bid in the treatment of benign gastric ulcer. Hepatogastroenterology 1991; 38: 400-3
    • (1991) Hepatogastroenterology , vol.38 , pp. 400-403
    • Cisternino, M.1
  • 98
    • 0028294158 scopus 로고
    • A double-blind, randomized, parallel group study of omeprazole and ranitidine in Korean patients with gastric ulcer
    • Choi KW, Sun HS, Yoon CM, et al. A double-blind, randomized, parallel group study of omeprazole and ranitidine in Korean patients with gastric ulcer. J Gastroenterol Hepatol 1994; 9: 118-23
    • (1994) J Gastroenterol Hepatol , vol.9 , pp. 118-123
    • Choi, K.W.1    Sun, H.S.2    Yoon, C.M.3
  • 99
    • 0028921061 scopus 로고
    • Efficacy of omeprazole versus famotidine in the short-term treatment of gastric ulcer
    • Lin CK, Lai KH, Lo GH, et al. Efficacy of omeprazole versus famotidine in the short-term treatment of gastric ulcer. Chin J Gastroenterol 1995; 11: 13-7
    • (1995) Chin J Gastroenterol , vol.11 , pp. 13-17
    • Lin, C.K.1    Lai, K.H.2    Lo, G.H.3
  • 100
    • 0023858976 scopus 로고
    • Effect of omeprazole and cimetidine on prepyloric gastric ulcer: Double blind comparative trial
    • Lauritsen K, Rune SJ, Wulff HR, et al. Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial. Gut 1988; 29: 249-53
    • (1988) Gut , vol.29 , pp. 249-253
    • Lauritsen, K.1    Rune, S.J.2    Wulff, H.R.3
  • 101
    • 0024453018 scopus 로고
    • Randomized, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer
    • Bate CM, Wilkinson SP, Bradby GVH, et al. Randomized, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer. Gut 1989; 30: 1323-8
    • (1989) Gut , vol.30 , pp. 1323-1328
    • Bate, C.M.1    Wilkinson, S.P.2    Bradby, G.V.H.3
  • 102
    • 0028225203 scopus 로고
    • Effect of omeprazole and sucralfate on prepyloric gastric ulcer. A double blind comparative trial and one year follow up
    • Sorensen HT, Hojgaard Rasmussen H, Balslev I, et al. Effect of omeprazole and sucralfate on prepyloric gastric ulcer. A double blind comparative trial and one year follow up. Gut 1994; 6: 837-40
    • (1994) Gut , vol.6 , pp. 837-840
    • Sorensen, H.T.1    Hojgaard Rasmussen, H.2    Balslev, I.3
  • 103
    • 0028306238 scopus 로고
    • Short report: Treatment of gastric ulcer with lansoprazole or ranitidine: a multicentre clinical trial
    • Michel P, Lemaire M, Colin R, et al. Short report: treatment of gastric ulcer with lansoprazole or ranitidine: a multicentre clinical trial. Aliment Pharm Ther 1994; 8: 119-22
    • (1994) Aliment Pharm Ther , vol.8 , pp. 119-122
    • Michel, P.1    Lemaire, M.2    Colin, R.3
  • 104
    • 85047236566 scopus 로고
    • Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: A preliminary trial
    • Okai T, Sawabu N, Songur Y, et al. Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: a preliminary trial. J Clin Gastroenterol 1995; 20: S32-S35
    • (1995) J Clin Gastroenterol , vol.20
    • Okai, T.1    Sawabu, N.2    Songur, Y.3
  • 105
    • 0029055902 scopus 로고
    • Evaluation of gastric ulcer healing by lansoprazole by measurement of ulcer diameter
    • Aoyama N, Kinoshita Y, Misaki F, et al. Evaluation of gastric ulcer healing by lansoprazole by measurement of ulcer diameter. J Clin Gastroenterol 1995; 20: S86-S89
    • (1995) J Clin Gastroenterol , vol.20
    • Aoyama, N.1    Kinoshita, Y.2    Misaki, F.3
  • 106
    • 0028870421 scopus 로고
    • Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer
    • Hotz J, Plein K, Schonekas H, et al. Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer. Scand J Gastroenterol 1995; 30: 111-5
    • (1995) Scand J Gastroenterol , vol.30 , pp. 111-115
    • Hotz, J.1    Plein, K.2    Schonekas, H.3
  • 107
    • 0005194756 scopus 로고
    • Clinical utility of E3810 for the treatment of gastric ulcer: Comparison with famotidine by multi-centre double blind study
    • Nakazawa S, Namiki M, Matsou Y, et al. Clinical utility of E3810 for the treatment of gastric ulcer: comparison with famotidine by multi-centre double blind study. Rinsho Hyoka 1993; 21: 337-59
    • (1993) Rinsho Hyoka , vol.21 , pp. 337-359
    • Nakazawa, S.1    Namiki, M.2    Matsou, Y.3
  • 108
    • 0028072951 scopus 로고
    • Efficacy and safety of lansoprazole in the treatment of gastric ulcer: A multicentre study
    • Florent C, Audigier JC, Boyer J, et al. Efficacy and safety of lansoprazole in the treatment of gastric ulcer: a multicentre study. Eur J Gastroenterol Hepatol 1994; 6: 1135-9
    • (1994) Eur J Gastroenterol Hepatol , vol.6 , pp. 1135-1139
    • Florent, C.1    Audigier, J.C.2    Boyer, J.3
  • 109
    • 0028967475 scopus 로고
    • Pantoprazole versus omeprazole in the treatment of acute gastric ulcers
    • Witzel L, Gutz H, Huttemann W, et al. Pantoprazole versus omeprazole in the treatment of acute gastric ulcers. Aliment Pharmacol Ther 1995; 9: 19-24
    • (1995) Aliment Pharmacol Ther , vol.9 , pp. 19-24
    • Witzel, L.1    Gutz, H.2    Huttemann, W.3
  • 110
    • 0345666902 scopus 로고    scopus 로고
    • Rabeprazole sodium 20 mg once daily is similar to omeprazole 20 mg once daily in the healing of active gastric ulcer
    • Dekkers CPM, Beker JA, Thjodleifsson B, et al. Rabeprazole sodium 20 mg once daily is similar to omeprazole 20 mg once daily in the healing of active gastric ulcer [abstract]. Gastroenterology 1997; 112: A99
    • (1997) Gastroenterology , vol.112
    • Dekkers, C.P.M.1    Beker, J.A.2    Thjodleifsson, B.3
  • 111
    • 0024780260 scopus 로고
    • Omeprazole in the management of refractory duodenal ulcer
    • Bardhan KD. Omeprazole in the management of refractory duodenal ulcer. Scand J Gastroenterol 1989; 24 Suppl.: 63-73
    • (1989) Scand J Gastroenterol , vol.24 , Issue.SUPPL. , pp. 63-73
    • Bardhan, K.D.1
  • 114
    • 0026052955 scopus 로고
    • 2-receptor antagonist-refractory ulcer: Its pathophysiology and treatment
    • 2-receptor antagonist-refractory ulcer: its pathophysiology and treatment. J Clin Gastroenterol 1991; 13 Suppl.: 129-33
    • (1991) J Clin Gastroenterol , vol.13 , Issue.SUPPL. , pp. 129-133
    • Arakawa, T.1    Higuchi, K.2    Fukuda, T.3
  • 116
    • 0024494239 scopus 로고
    • Campylobacter pylori and peptic ulcer disease
    • Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989; 96: 615-25
    • (1989) Gastroenterology , vol.96 , pp. 615-625
    • Graham, D.Y.1
  • 117
    • 0025859273 scopus 로고
    • Duodenal ulcer: The villain unmasked?
    • Axon AR. Duodenal ulcer: the villain unmasked? BMJ 1991; 302: 919-21
    • (1991) BMJ , vol.302 , pp. 919-921
    • Axon, A.R.1
  • 119
    • 0025945933 scopus 로고
    • Helicobacter pylori infection and the risk of gastric carcinoma
    • Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31
    • (1991) N Engl J Med , vol.325 , pp. 1127-1131
    • Parsonnet, J.1    Friedman, G.D.2    Vandersteen, D.P.3
  • 120
    • 0026050956 scopus 로고
    • Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii
    • Nomura A, Stemmermann GN, Chyou PH, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132-6
    • (1991) N Engl J Med , vol.325 , pp. 1132-1136
    • Nomura, A.1    Stemmermann, G.N.2    Chyou, P.H.3
  • 121
    • 0025871037 scopus 로고
    • Association between infection with Helicobacter pylori and risk of gastric cancer. Evidence from a prospective investigation
    • Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer. Evidence from a prospective investigation. BMJ 1991; 302: 1302-5
    • (1991) BMJ , vol.302 , pp. 1302-1305
    • Forman, D.1    Newell, D.G.2    Fullerton, F.3
  • 122
    • 0031906734 scopus 로고    scopus 로고
    • Helicobacter pylori infection and gastric lymphoma
    • Wotherspoon AC. Helicobacter pylori infection and gastric lymphoma. Br Med Bull 1998; 54: 79-85
    • (1998) Br Med Bull , vol.54 , pp. 79-85
    • Wotherspoon, A.C.1
  • 123
    • 0023851732 scopus 로고
    • Campylobacter pylori-associated chronic active antral gastritis: A prospective study of its prevalence and the effects of anti-bacterial and anti-ulcer treatment
    • Rauws EA, Langenberg W, Houthoff HJ, et al. Campylobacter pylori-associated chronic active antral gastritis: a prospective study of its prevalence and the effects of anti-bacterial and anti-ulcer treatment. Gastroenterology 1988; 94: 33-40
    • (1988) Gastroenterology , vol.94 , pp. 33-40
    • Rauws, E.A.1    Langenberg, W.2    Houthoff, H.J.3
  • 124
    • 0028032159 scopus 로고
    • Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa
    • Crabtree JE, Wyatt JI, Trejdosiewic LK, et al. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol 1994; 47: 61-6
    • (1994) J Clin Pathol , vol.47 , pp. 61-66
    • Crabtree, J.E.1    Wyatt, J.I.2    Trejdosiewic, L.K.3
  • 125
    • 0028361702 scopus 로고
    • Helicobacter pylori in peptic ulcer disease
    • NIH Consensus Development Panel. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-9
    • (1994) JAMA , vol.272 , pp. 65-69
  • 126
    • 0002841701 scopus 로고    scopus 로고
    • Guidelines for clinical trials in H. pylori infection
    • Working Party of the European H. pylori Study Group
    • Guidelines for clinical trials in H. pylori infection. Working Party of the European H. pylori Study Group. Gut 1997; 42: S10-S18
    • (1997) Gut , vol.42
  • 127
    • 0028298836 scopus 로고
    • Activity of omeprazole on H. pylori and relation to toxicity of strains
    • Figura N, Armellini D, Bugnoli M, et al. Activity of omeprazole on H. pylori and relation to toxicity of strains. J Clin Pathol 1994; 47: 440-2
    • (1994) J Clin Pathol , vol.47 , pp. 440-442
    • Figura, N.1    Armellini, D.2    Bugnoli, M.3
  • 128
    • 7344263199 scopus 로고
    • Omeprazole exerts the same inhibitory effect on the growth of cytotoxic-positive and cytotoxic-negalive H. pylori strains and does not inhibit vacuolating toxin production
    • Lage AP, Glupczynski Y. Omeprazole exerts the same inhibitory effect on the growth of cytotoxic-positive and cytotoxic-negalive H. pylori strains and does not inhibit vacuolating toxin production. Eur J Gastroenterol 1994; 6: 209-301
    • (1994) Eur J Gastroenterol , vol.6 , pp. 209-301
    • Lage, A.P.1    Glupczynski, Y.2
  • 129
    • 0025874987 scopus 로고
    • Activity of lansoprazole against Helicobacter pylori
    • Megraud F, Boyanova L, Lamouliatte H. Activity of lansoprazole against Helicobacter pylori [letler]. Lancet 1991; 337: 1486
    • (1991) Lancet , vol.337 , pp. 1486
    • Megraud, F.1    Boyanova, L.2    Lamouliatte, H.3
  • 130
    • 0026060039 scopus 로고
    • Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori
    • Iwahi T, Satoh H, Nakao M, et al. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother 1991; 35 (3): 490-6
    • (1991) Antimicrob Agents Chemother , vol.35 , Issue.3 , pp. 490-496
    • Iwahi, T.1    Satoh, H.2    Nakao, M.3
  • 131
    • 0026111734 scopus 로고
    • Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori
    • Suerbaum S, Leying H, Klemm K, et al. Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1991; Feb; 10: 92-3
    • (1991) Eur J Clin Microbiol Infect Dis , vol.FEB , Issue.10 , pp. 92-93
    • Suerbaum, S.1    Leying, H.2    Klemm, K.3
  • 132
    • 0027405296 scopus 로고
    • Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: Unique action selective for H. pylori cells
    • Nagata K, Satoh H, Iwahi T, et al. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells. Antimicrob Agents Chemother 1993; 37: 769-74
    • (1993) Antimicrob Agents Chemother , vol.37 , pp. 769-774
    • Nagata, K.1    Satoh, H.2    Iwahi, T.3
  • 133
    • 0027261291 scopus 로고
    • Inhibition of Helicobacter pylori urease by omeprazole
    • Bugnoli M, Bayeli PF, Rappuoli R, et al. Inhibition of Helicobacter pylori urease by omeprazole. Eur J Gastroenterol 1993; 5: 683-6
    • (1993) Eur J Gastroenterol , vol.5 , pp. 683-686
    • Bugnoli, M.1    Bayeli, P.F.2    Rappuoli, R.3
  • 134
    • 0029114569 scopus 로고
    • Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor
    • Tsuchiya M, Imamura L, Park JB, et al. Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor. Biol Pharm Bull 1995; 18(8): 1053-6
    • (1995) Biol Pharm Bull , vol.18 , Issue.8 , pp. 1053-1056
    • Tsuchiya, M.1    Imamura, L.2    Park, J.B.3
  • 135
    • 0028843354 scopus 로고
    • Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: Inhibition of growth is not related to inhibition of urease
    • Nagata K, Takagi E, Tsuda M, et al. Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease. Antimicrob Agents Chemother 1995; 3(2): 567-70
    • (1995) Antimicrob Agents Chemother , vol.3 , Issue.2 , pp. 567-570
    • Nagata, K.1    Takagi, E.2    Tsuda, M.3
  • 136
    • 0029918613 scopus 로고    scopus 로고
    • In vitro antibacterial activity of omeprazole and its selectivity for Helicobacter spp. are dependent on incubation conditions
    • Sjostrom JE, Fryklund J, Kuhler T, et al. In vitro antibacterial activity of omeprazole and its selectivity for Helicobacter spp. are dependent on incubation conditions. Antimicrob Agents Chemother 1996; 40 (3): 621-6
    • (1996) Antimicrob Agents Chemother , vol.40 , Issue.3 , pp. 621-626
    • Sjostrom, J.E.1    Fryklund, J.2    Kuhler, T.3
  • 137
    • 0030049829 scopus 로고    scopus 로고
    • + inhibitors on Helicobacter pylori infection
    • + inhibitors on Helicobacter pylori infection. Pharmacol Ther 1996; 69 (1): 79-83
    • (1996) Pharmacol Ther , vol.69 , Issue.1 , pp. 79-83
    • Logan, R.P.H.1
  • 138
    • 0000243754 scopus 로고
    • Effect of omeprazole on Helicobacter pylori
    • Sharp J, Logan RPH, Walker MM, et al. Effect of omeprazole on Helicobacter pylori [abstract]. Gut 1991; 32: A565
    • (1991) Gut , vol.32
    • Sharp, J.1    Logan, R.P.H.2    Walker, M.M.3
  • 139
    • 0026667217 scopus 로고
    • Omeprazole may clear but does not eradicate H. pylori
    • Louw JA, Zak J, Jaskiewicz K, et al. Omeprazole may clear but does not eradicate H. pylori. Eur J Gastroenterol Hepatol 1992; 4(6): 481-5
    • (1992) Eur J Gastroenterol Hepatol , vol.4 , Issue.6 , pp. 481-485
    • Louw, J.A.1    Zak, J.2    Jaskiewicz, K.3
  • 140
    • 0028796710 scopus 로고
    • Institution Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole
    • Logan RPH, Walker MM, Misiewicz JJ, et al. Institution Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995; 36 (1): 12-6
    • (1995) Gut , vol.36 , Issue.1 , pp. 12-16
    • Logan, R.P.H.1    Walker, M.M.2    Misiewicz, J.J.3
  • 141
    • 0029054150 scopus 로고
    • Detection of the intragastric sites at which Helicobacter pylori evades treatment with amoxycillin and cimetidine
    • Atherton JC, Cockayne A, Balsitis M, et al. Detection of the intragastric sites at which Helicobacter pylori evades treatment with amoxycillin and cimetidine. Gut 1995 36(5): 670-4
    • (1995) Gut , vol.36 , Issue.5 , pp. 670-674
    • Atherton, J.C.1    Cockayne, A.2    Balsitis, M.3
  • 142
    • 0029821733 scopus 로고    scopus 로고
    • Helicobacter pylori does not migrate from the antrum to the corpus in response to omeprazole
    • Graham DY, Genta R, Evans DG, et al. Helicobacter pylori does not migrate from the antrum to the corpus in response to omeprazole. Am J Gastroenterol 1996; 91 (10): 2120-4
    • (1996) Am J Gastroenterol , vol.91 , Issue.10 , pp. 2120-2124
    • Graham, D.Y.1    Genta, R.2    Evans, D.G.3
  • 143
    • 0029815909 scopus 로고    scopus 로고
    • The proton motive force of Helicobacter pylori determines its survival in the gastrointestinal tract
    • Meyer-Rosenberg K, Scott DR, Melchers K, et al. The proton motive force of Helicobacter pylori determines its survival in the gastrointestinal tract. Gastroenterology 1996; 111 (4): 886-900
    • (1996) Gastroenterology , vol.111 , Issue.4 , pp. 886-900
    • Meyer-Rosenberg, K.1    Scott, D.R.2    Melchers, K.3
  • 144
    • 0030017760 scopus 로고    scopus 로고
    • Effect of omeprazole on the distribution of metronidazole, amoxycillin, and clarithromycin in human gastric juice
    • Goddard AF, Jessa MJ, Barrett DA, et al. Effect of omeprazole on the distribution of metronidazole, amoxycillin, and clarithromycin in human gastric juice. Gastroenterology 1996; 111 (2): 358-67
    • (1996) Gastroenterology , vol.111 , Issue.2 , pp. 358-367
    • Goddard, A.F.1    Jessa, M.J.2    Barrett, D.A.3
  • 145
    • 0026705206 scopus 로고
    • High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori
    • Bayerdorffer E, Mannes GA, Sommer A, et al. High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol 1992; 4(9) 697-702
    • (1992) Eur J Gastroenterol Hepatol , vol.4 , Issue.9 , pp. 697-702
    • Bayerdorffer, E.1    Mannes, G.A.2    Sommer, A.3
  • 146
    • 0031052364 scopus 로고    scopus 로고
    • Eradication of Helicobacter pylori: An objective assessment of current therapies
    • Penston JG, McColl KEL. Eradication of Helicobacter pylori: an objective assessment of current therapies. Br J Clin Pharmacol 1997; 43: 223-43
    • (1997) Br J Clin Pharmacol , vol.43 , pp. 223-243
    • Penston, J.G.1    McColl, K.E.L.2
  • 147
    • 0028936506 scopus 로고
    • Low dose clarithromycin plus omeprazole eradicates Helicobacter pylori in duodenal ulcer disease
    • Kadayifci A, Simsek H, Arslan M, et al. Low dose clarithromycin plus omeprazole eradicates Helicobacter pylori in duodenal ulcer disease. Am J Gastroenterol 1995; 90 (3) 519-20
    • (1995) Am J Gastroenterol , vol.90 , Issue.3 , pp. 519-520
    • Kadayifci, A.1    Simsek, H.2    Arslan, M.3
  • 148
    • 0028288729 scopus 로고
    • Eradication of Helicobacter pylori with clarithromycin and omeprazole
    • Logan RPH, Gummett PA, Schaufelberger H, et al. Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 1994; 35 (3): 323-6
    • (1994) Gut , vol.35 , Issue.3 , pp. 323-326
    • Logan, R.P.H.1    Gummett, P.A.2    Schaufelberger, H.3
  • 149
    • 4244100027 scopus 로고    scopus 로고
    • Rabeprazole is effective and safe when used in combination with antibiotics for the eradication of Helicobacter pylori
    • Stack WA, Knifton A, Jenkins D, et al. Rabeprazole is effective and safe when used in combination with antibiotics for the eradication of Helicobacter pylori [abstract]. Gut 1997; 41 Suppl. 3: A205
    • (1997) Gut , vol.41 , Issue.3 SUPPL.
    • Stack, W.A.1    Knifton, A.2    Jenkins, D.3
  • 150
    • 0030223132 scopus 로고    scopus 로고
    • Eradication of H. pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH-1 study
    • Lind T, Velduyzen van Zanten S, Unge P, et al. Eradication of H. pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH-1 study. Helicobacter 1996; 3: 138-44
    • (1996) Helicobacter , vol.3 , pp. 138-144
    • Lind, T.1    Velduyzen Van Zanten, S.2    Unge, P.3
  • 151
    • 0013607192 scopus 로고    scopus 로고
    • One week triple therapy for eradication of H. pylori: A multicentre randomized trial
    • Misiewicz JJ, Harris AW, Bardhan KD, et al. One week triple therapy for eradication of H. pylori: a multicentre randomized trial. Gut 1997; 41 (6) 735-9
    • (1997) Gut , vol.41 , Issue.6 , pp. 735-739
    • Misiewicz, J.J.1    Harris, A.W.2    Bardhan, K.D.3
  • 152
    • 0031000530 scopus 로고    scopus 로고
    • Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: A randomized controlled trial
    • Svoboda P, Kantorova I, Ochmann JJ, et al. Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: a randomized controlled trial. Hepatogastroenterology 1997; 44 (15): 886-90
    • (1997) Hepatogastroenterology , vol.44 , Issue.15 , pp. 886-890
    • Svoboda, P.1    Kantorova, I.2    Ochmann, J.J.3
  • 153
    • 0029803993 scopus 로고    scopus 로고
    • Triple therapy as a cure for H. pylori infection
    • Bardhan KD. Triple therapy as a cure for H. pylori infection. Eur J Gastroenterol Hepatol 1996; 8 Suppl. 1: S27-S30
    • (1996) Eur J Gastroenterol Hepatol , vol.8 , Issue.1 SUPPL.
    • Bardhan, K.D.1
  • 154
    • 0031050777 scopus 로고    scopus 로고
    • Highly effective twice daily therapies for Helicobacter pylori infection and peptic ulcer disease: Does in vitro metronidazole resistance have any clinical relevance?
    • Lerang F, Moum B, Haug JB, et al. Highly effective twice daily therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? Am J Gastroenterol 1997; 92: 248-53
    • (1997) Am J Gastroenterol , vol.92 , pp. 248-253
    • Lerang, F.1    Moum, B.2    Haug, J.B.3
  • 155
    • 0029949471 scopus 로고    scopus 로고
    • Choosing the best anti-Helicobacter therapy: Effect of antimicrobial resistance
    • Graham DY, de Boer WA, Tytgal GN. Choosing the best anti-Helicobacter therapy: effect of antimicrobial resistance. Am J Gastroenterol 1996; 91: 1072-6
    • (1996) Am J Gastroenterol , vol.91 , pp. 1072-1076
    • Graham, D.Y.1    De Boer, W.A.2    Tytgal, G.N.3
  • 156
    • 0029901103 scopus 로고    scopus 로고
    • How to treat Helicobacter infection. Should treatment strategies be based on testing bacterial susceptibility?
    • DeBoer WA, Tytgat GNJ. How to treat Helicobacter infection. Should treatment strategies be based on testing bacterial susceptibility? Eur J Gastroenterol Hepatol 1996; 8: 709-16
    • (1996) Eur J Gastroenterol Hepatol , vol.8 , pp. 709-716
    • DeBoer, W.A.1    Tytgat, G.N.J.2
  • 157
    • 0028828333 scopus 로고
    • Omeprazole enhances efficacy of triple therapy in the eradication of H. pylori
    • Borody TJ, Andrews P, Fracchia G, et al. Omeprazole enhances efficacy of triple therapy in the eradication of H. pylori. Gut 1995; 37: 477-81
    • (1995) Gut , vol.37 , pp. 477-481
    • Borody, T.J.1    Andrews, P.2    Fracchia, G.3
  • 158
    • 0025019780 scopus 로고
    • Non-steroidal anti-inflammatory drugs and ulcers: Facts and figures multiply, but do they add up?
    • Hawkey CJ. Non-steroidal anti-inflammatory drugs and ulcers: facts and figures multiply, but do they add up? BMJ 1990; 300: 278-84
    • (1990) BMJ , vol.300 , pp. 278-284
    • Hawkey, C.J.1
  • 159
    • 0032510378 scopus 로고    scopus 로고
    • Omeprazole compared with misoprostol for ulcers associated with non-steroidal inflammatory drugs. The OMNIUM study
    • Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with non-steroidal inflammatory drugs. The OMNIUM study. N Engl J Med 1998; 338: 727-34
    • (1998) N Engl J Med , vol.338 , pp. 727-734
    • Hawkey, C.J.1    Karrasch, J.A.2    Szczepanski, L.3
  • 160
    • 0032510315 scopus 로고    scopus 로고
    • A comparison of omeprazole with ranitidine for ulcers associated with non-steroidal anti-inflammatory drugs. The ASTRONAUT study
    • Yeomans ND, Tulassay Z, Juhasz L, et al. A comparison of omeprazole with ranitidine for ulcers associated with non-steroidal anti-inflammatory drugs. The ASTRONAUT study. N Engl J Med 1998; 338: 719-26
    • (1998) N Engl J Med , vol.338 , pp. 719-726
    • Yeomans, N.D.1    Tulassay, Z.2    Juhasz, L.3
  • 161
    • 0025345299 scopus 로고
    • Abolition by omeprazole of aspirin-induced gastric mucosal injury in man
    • Daneshmend TK, Stein AG, Bhaskar NK, et al. Abolition by omeprazole of aspirin-induced gastric mucosal injury in man. Gut 1990; 31: 514-7
    • (1990) Gut , vol.31 , pp. 514-517
    • Daneshmend, T.K.1    Stein, A.G.2    Bhaskar, N.K.3
  • 162
    • 0024452662 scopus 로고
    • Use of microbleeding and an ultrathin endoscope to assess gastric mucosal protection by famotidine
    • Daneshmend TK, Pritchard PH, Bhaskar NK, et al. Use of microbleeding and an ultrathin endoscope to assess gastric mucosal protection by famotidine. Gastroenterology 1989; 97: 944-9
    • (1989) Gastroenterology , vol.97 , pp. 944-949
    • Daneshmend, T.K.1    Pritchard, P.H.2    Bhaskar, N.K.3
  • 163
    • 9344236529 scopus 로고    scopus 로고
    • Famotidine for the prevention of gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs
    • Taha AS, Hudson N, Hawkey CJ, et al. Famotidine for the prevention of gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs. N Engl J Med 1996; 334: 1435-9
    • (1996) N Engl J Med , vol.334 , pp. 1435-1439
    • Taha, A.S.1    Hudson, N.2    Hawkey, C.J.3
  • 164
    • 0030016432 scopus 로고    scopus 로고
    • Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non steroidal anti-inflammatory drug therapy: A Nordic multicentre study
    • Ekström P, Carling L, Wetterhus S, et al. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non steroidal anti-inflammatory drug therapy: a Nordic multicentre study. Scand J Gastroenterol 1996; 31: 753-8
    • (1996) Scand J Gastroenterol , vol.31 , pp. 753-758
    • Ekström, P.1    Carling, L.2    Wetterhus, S.3
  • 165
    • 0031975071 scopus 로고    scopus 로고
    • Primary gastroduodenal prophylaxis with omeprazole for NSAID users
    • Cullen D, Bardhan KD, Eisner M, et al. Primary gastroduodenal prophylaxis with omeprazole for NSAID users. Aliment Pharmacol Ther 1998; 12: 135-40
    • (1998) Aliment Pharmacol Ther , vol.12 , pp. 135-140
    • Cullen, D.1    Bardhan, K.D.2    Eisner, M.3
  • 166
    • 8544260301 scopus 로고    scopus 로고
    • Effect of lansoprazole against peptic ulcers induced by non-steroidal anti-inflammatory drugs: Endoscopic evaluation of ulcer healing
    • Matsukawa Y, Tomita Y, Nishinarita S, et al. Effect of lansoprazole against peptic ulcers induced by non-steroidal anti-inflammatory drugs: endoscopic evaluation of ulcer healing. J Int Med Res 1997; 25: 190-5
    • (1997) J Int Med Res , vol.25 , pp. 190-195
    • Matsukawa, Y.1    Tomita, Y.2    Nishinarita, S.3
  • 167
    • 0030813408 scopus 로고    scopus 로고
    • Randomized eradication of H. pylori before non steroidal anti-inflammatory drug therapy to prevent peptic ulcers
    • Chan FKL, Sung JJY, Chung SCS, et al. Randomized eradication of H. pylori before non steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997; 350: 975-9
    • (1997) Lancet , vol.350 , pp. 975-979
    • Chan, F.K.L.1    Sung, J.J.Y.2    Chung, S.C.S.3
  • 168
    • 4243259850 scopus 로고    scopus 로고
    • Large six month trial of Helicobacter pylori eradication for lesion prevention in NSAID users
    • Hawkey CJ, Nottingham GI Trials Service. Large six month trial of Helicobacter pylori eradication for lesion prevention in NSAID users [abstract]. Gut 1997; 41 (3): A197
    • (1997) Gut , vol.41 , Issue.3
    • Hawkey, C.J.1    Nottingham, G.I.2
  • 169
    • 0001704386 scopus 로고    scopus 로고
    • Eradication of H. pylori versus maintenance acid suppression to prevent recurrent ulcer hemorrhage in high risk NSAID users: A prospective randomized study
    • Chan FKL, Sung JY, Suen R, et al. Eradication of H. pylori versus maintenance acid suppression to prevent recurrent ulcer hemorrhage in high risk NSAID users: a prospective randomized study [abstract]. Gastroenterology 1998; 114: A87
    • (1998) Gastroenterology , vol.114
    • Chan, F.K.L.1    Sung, J.Y.2    Suen, R.3
  • 170
    • 0025104519 scopus 로고
    • Pathophysiology of gastroesophageal reflux: Lower esophageal sphincter dysfunction in gastroesophageal reflux disease
    • Holloway RH, Dent J. Pathophysiology of gastroesophageal reflux: lower esophageal sphincter dysfunction in gastroesophageal reflux disease. Gastroenterol Clin North Am 1990; 19: 517-35
    • (1990) Gastroenterol Clin North Am , vol.19 , pp. 517-535
    • Holloway, R.H.1    Dent, J.2
  • 171
    • 0027490573 scopus 로고
    • Does 40 mg omeprazole daily offer additional benefit over 20 mg daily in patients requiring more than 4 weeks of treatment for symptomatic reflux oesophagitis?
    • Bate CM, Booth SN, Crowe JP, et al. Does 40 mg omeprazole daily offer additional benefit over 20 mg daily in patients requiring more than 4 weeks of treatment for symptomatic reflux oesophagitis? Aliment Pharmacol Ther 1993; 7: 501-7
    • (1993) Aliment Pharmacol Ther , vol.7 , pp. 501-507
    • Bate, C.M.1    Booth, S.N.2    Crowe, J.P.3
  • 172
    • 0026768776 scopus 로고
    • Open study of the clinical effects of lansoprazole in the treatment of re flux oesophagitis
    • Sekiguchi T, Matsuzaki T, Horikoshi T, et al. Open study of the clinical effects of lansoprazole in the treatment of re flux oesophagitis. Drug Invest 1992; 4: 422-34
    • (1992) Drug Invest , vol.4 , pp. 422-434
    • Sekiguchi, T.1    Matsuzaki, T.2    Horikoshi, T.3
  • 173
    • 0028909758 scopus 로고
    • 2-receptor antagonist therapy. Lansoprazole, a new proton pump inhibitor
    • 2-receptor antagonist therapy. Lansoprazole, a new proton pump inhibitor. Dig Dis Sci 1995; 40: 590-7
    • (1995) Dig Dis Sci , vol.40 , pp. 590-597
    • Robinson, M.1    Campbell, D.R.2    Sontag, S.3
  • 174
    • 9344222729 scopus 로고    scopus 로고
    • Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis
    • Van Rensburg CJ, Honiball CJ, De Grundling HK, et al. Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis. Aliment Pharmacol Ther 1996; 10: 397-401
    • (1996) Aliment Pharmacol Ther , vol.10 , pp. 397-401
    • Van Rensburg, C.J.1    Honiball, C.J.2    De Grundling, H.K.3
  • 175
    • 0023115291 scopus 로고
    • Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis
    • Klinkenberg-Knol EC, Festen HPM, Jansen JM, et al. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet 1987; I: 349-51
    • (1987) Lancet , vol.1 , pp. 349-351
    • Klinkenberg-Knol, E.C.1    Festen, H.P.M.2    Jansen, J.M.3
  • 176
    • 0023814934 scopus 로고
    • Omeprazole (40mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis
    • Vantrappen G, Rutgeerts L, Schurmans P, et al. Omeprazole (40mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis. Dig Dis Sci 1988; 33: 523-9
    • (1988) Dig Dis Sci , vol.33 , pp. 523-529
    • Vantrappen, G.1    Rutgeerts, L.2    Schurmans, P.3
  • 177
    • 0025061538 scopus 로고
    • Comparison of omeprazole and cimetidine in reflux oesophagitis: Symptomatic, endoscopic and histological evaluations
    • Bate CM, Keeling PWN, O'Morain C, et al. Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic and histological evaluations. Gut 1990; 31: 968-72
    • (1990) Gut , vol.31 , pp. 968-972
    • Bate, C.M.1    Keeling, P.W.N.2    O'Morain, C.3
  • 179
    • 0025754033 scopus 로고
    • 2-blocker-resistant esophagitis
    • 2-blocker-resistant esophagitis. Dig Dis Sci 1991; 36: 552-7
    • (1991) Dig Dis Sci , vol.36 , pp. 552-557
    • Koop, H.1    Arnold, R.2
  • 180
    • 0027182616 scopus 로고
    • 2-receptor antagonists with lansoprazole, a new H+/K+-ATPase inhibitor: A controlled double-blind study
    • 2-receptor antagonists with lansoprazole, a new H+/K+-ATPase inhibitor: a controlled double-blind study. Am J Gastroenterol 1993; 8: 1212-7
    • (1993) Am J Gastroenterol , vol.8 , pp. 1212-1217
    • Feldman, M.1    Harford, W.V.2    Fisher, R.S.3
  • 181
    • 0028943470 scopus 로고
    • Lansoprazole versus ranitidine for the treatment of reflux oesophagitis
    • Bardhan KD, Hawkey CJ, Long RG, et al. Lansoprazole versus ranitidine for the treatment of reflux oesophagitis. Aliment Pharmacol Ther 1995; 9: 145-51
    • (1995) Aliment Pharmacol Ther , vol.9 , pp. 145-151
    • Bardhan, K.D.1    Hawkey, C.J.2    Long, R.G.3
  • 182
    • 0030741624 scopus 로고    scopus 로고
    • Efficacy of therapy with lansoprazole in patients with acute reflux esophagitis compared with ranitidine
    • Plein K, Stolte M, Fuchs W, et al. Efficacy of therapy with lansoprazole in patients with acute reflux esophagitis compared with ranitidine. Leber Magen Darm 1997; 27: 145-6, 149-53
    • (1997) Leber Magen Darm , vol.27 , pp. 145-146
    • Plein, K.1    Stolte, M.2    Fuchs, W.3
  • 183
    • 0028964575 scopus 로고
    • Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis: Results of a German multicenter study
    • Koop H, Schepp W, Dammann HG, et al. Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis: results of a German multicenter study. J Clin Gastroenterol 1995; 20: 192-5
    • (1995) J Clin Gastroenterol , vol.20 , pp. 192-195
    • Koop, H.1    Schepp, W.2    Dammann, H.G.3
  • 184
    • 0000972087 scopus 로고    scopus 로고
    • Rabeprazole sodium (E3810) once daily is superior to ranitidine 150mg QID in the healing of erosive or ulcerative oesophagitis
    • TJ Humphries, Spera A, Breiter P, et al. Rabeprazole sodium (E3810) once daily is superior to ranitidine 150mg QID in the healing of erosive or ulcerative oesophagitis [abstract]. Gastroenterology 1996; 110: A139
    • (1996) Gastroenterology , vol.110
    • Humphries, T.J.1    Spera, A.2    Breiter, P.3
  • 185
    • 0024337172 scopus 로고
    • Omeprazole versus ranitidine in reflux oesophagitis: Results of a double blind randomized trial
    • Zeitoun R, Ramal P, Barbier P. Omeprazole versus ranitidine in reflux oesophagitis: results of a double blind randomized trial. Gastroenterol Clin Bull 1989; 13: 457-62
    • (1989) Gastroenterol Clin Bull , vol.13 , pp. 457-462
    • Zeitoun, R.1    Ramal, P.2    Barbier, P.3
  • 186
    • 0023922956 scopus 로고
    • Omeprazole or ranitidine in the treatment of reflux oesophagitis: Results of a double blind randomized Scandinavian multi-center study
    • Sandmark S, Carlsson R, Fausa O, et al. Omeprazole or ranitidine in the treatment of reflux oesophagitis: results of a double blind randomized Scandinavian multi-center study. Scand J Gastroenterol 1988; 23: 625-32
    • (1988) Scand J Gastroenterol , vol.23 , pp. 625-632
    • Sandmark, S.1    Carlsson, R.2    Fausa, O.3
  • 187
    • 0029067755 scopus 로고
    • Treatment and prevention of relapse of mild oesophagitis with omeprazole and cisapride. Comparison of two strategies
    • Kimmig JM. Treatment and prevention of relapse of mild oesophagitis with
    • (1995) Aliment Pharmacol Ther , vol.9 , pp. 281-286
    • Kimmig, J.M.1
  • 188
    • 0028853629 scopus 로고
    • A comparison of five maintenance therapies for reflux oesophagitis
    • Vigneri S, Termini R, Leandro G, et al. A comparison of five maintenance therapies for reflux oesophagitis. N Engl J Med 1995; 333: 1106-10
    • (1995) N Engl J Med , vol.333 , pp. 1106-1110
    • Vigneri, S.1    Termini, R.2    Leandro, G.3
  • 189
    • 0030883417 scopus 로고    scopus 로고
    • Treating the symptoms of gastroesophageal reflux disease: A double-blind comparison of omeprazole and cisapride
    • Galmiche JP, Barthelemy H, Hamelin B. Treating the symptoms of gastroesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther 1997; 11: 765-73
    • (1997) Aliment Pharmacol Ther , vol.11 , pp. 765-773
    • Galmiche, J.P.1    Barthelemy, H.2    Hamelin, B.3
  • 190
    • 0029839659 scopus 로고    scopus 로고
    • Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis
    • Castell DO, Richter JE, Robinson M, et al. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. Am J Gastroenterol 1996; 91: 1749-57
    • (1996) Am J Gastroenterol , vol.91 , pp. 1749-1757
    • Castell, D.O.1    Richter, J.E.2    Robinson, M.3
  • 191
    • 0028800448 scopus 로고
    • Lansoprazole versus omeprazole in the treatment of reflux oesophagitis
    • Petite JP, Salducci J, Grimaud JC, et al. Lansoprazole versus omeprazole in the treatment of reflux oesophagitis. Med Chir Dig 1995; 24: 291-4
    • (1995) Med Chir Dig , vol.24 , pp. 291-294
    • Petite, J.P.1    Salducci, J.2    Grimaud, J.C.3
  • 192
    • 0029797692 scopus 로고    scopus 로고
    • Rapid symptom relief in reflux oesophagitis: A comparison of lansoprazole and omeprazole
    • Mee AS, Rowley JL. Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole. Aliment Pharmacol Ther 1996; 10: 757-63
    • (1996) Aliment Pharmacol Ther , vol.10 , pp. 757-763
    • Mee, A.S.1    Rowley, J.L.2
  • 193
    • 0029846260 scopus 로고    scopus 로고
    • Lansoprazole 30 mg versus omeprazole 40 mg in the treatment of reflux oesophagitis grade II, III and IVA (a Dutch multicentre trial)
    • Mulder CJ, Dekker W, Gerretsen M. Lansoprazole 30 mg versus omeprazole 40 mg in the treatment of reflux oesophagitis grade II, III and IVA (a Dutch multicentre trial). Eur J Gastroenterol Hepatol 1996; 8: 1101-6
    • (1996) Eur J Gastroenterol Hepatol , vol.8 , pp. 1101-1106
    • Mulder, C.J.1    Dekker, W.2    Gerretsen, M.3
  • 194
    • 0029012786 scopus 로고
    • A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: A multicentre trial
    • Mossner J, Holscher AH, Herz R, et al. A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: a multicentre trial. Aliment Pharmacol Ther 1995; 9: 321-6
    • (1995) Aliment Pharmacol Ther , vol.9 , pp. 321-326
    • Mossner, J.1    Holscher, A.H.2    Herz, R.3
  • 195
    • 0029565402 scopus 로고
    • Pantoprazole and omeprazole in the treatment of reflux oesophagitis: A European multicentre study
    • Corinaldesi R, Valentini M, Belaiche J, et al. Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study. Aliment Pharmacol Ther 1995; 9: 667-71
    • (1995) Aliment Pharmacol Ther , vol.9 , pp. 667-671
    • Corinaldesi, R.1    Valentini, M.2    Belaiche, J.3
  • 196
    • 0000941170 scopus 로고    scopus 로고
    • Rabeprazole 20 mg/day is similar to omeprazole 20mg/day in the treatment of erosive or ulcerative oesophagitis
    • Thjodleifsson B, Dekkers CPM, Beker JA, et al. Rabeprazole 20 mg/day is similar to omeprazole 20mg/day in the treatment of erosive or ulcerative oesophagitis [abstract]. Gastroenterology 1997; 112: A312
    • (1997) Gastroenterology , vol.112
    • Thjodleifsson, B.1    Dekkers, C.P.M.2    Beker, J.A.3
  • 197
    • 0029083624 scopus 로고
    • Omeprazole in the long-term treatment of gastro-oesophageal reflux disease: A double-blind randomized dose-finding study
    • Slaerk-Laursen L, Havelund T, Bondesen S, et al. Omeprazole in the long-term treatment of gastro-oesophageal reflux disease: a double-blind randomized dose-finding study. Scand J Gastroenterology 1995; 30: 839-46
    • (1995) Scand J Gastroenterology , vol.30 , pp. 839-846
    • Slaerk-Laursen, L.1    Havelund, T.2    Bondesen, S.3
  • 198
    • 0029822777 scopus 로고    scopus 로고
    • Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease
    • Jaspersen D, Schwacha H, Schorr W, et al. Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease. J Gastroenterol Hepatol 1996; 11: 900-2
    • (1996) J Gastroenterol Hepatol , vol.11 , pp. 900-902
    • Jaspersen, D.1    Schwacha, H.2    Schorr, W.3
  • 199
    • 0026083103 scopus 로고
    • Prevention of relapse of reflux esophagitis after endoscopic healing: The efficacy and safety of omeprazole compared with ranitidine
    • Lundell L, Backman L, Ekstrom P, et al. Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Scand J Gastroenterol 1991; 26: 248-56
    • (1991) Scand J Gastroenterol , vol.26 , pp. 248-256
    • Lundell, L.1    Backman, L.2    Ekstrom, P.3
  • 200
    • 0028968545 scopus 로고
    • Omeprazole 10mg or 20mg once daily in the prevention of recurrence of reflux oesophagitis
    • Bate CM, Booth SN, Crowe JR et al. Omeprazole 10mg or 20mg once daily in the prevention of recurrence of reflux oesophagitis. Gut 1995; 36 (4): 492-8
    • (1995) Gut , vol.36 , Issue.4 , pp. 492-498
    • Bate, C.M.1    Booth, S.N.2    Crowe, J.R.3
  • 201
    • 0024988305 scopus 로고
    • Omeprazole or high dose ranitidine in the treatment of patients with reflux oesophagitis not responding to standard doses of H2 receptor antagonists
    • Lundell L, Backman L, Ekstom P, et al. Omeprazole or high dose ranitidine in the treatment of patients with reflux oesophagitis not responding to standard doses of H2 receptor antagonists. Aliment Pharmacol Ther 1990; 4: 145-55
    • (1990) Aliment Pharmacol Ther , vol.4 , pp. 145-155
    • Lundell, L.1    Backman, L.2    Ekstom, P.3
  • 202
    • 0025602067 scopus 로고
    • Prevention of relapse of reflux oesophagitis after endoscopic healing: The efficacy and safety of omeprazole compared with ranitidine
    • Lundell L. Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Digestion 1990; 47 Suppl. 1: 72-5
    • (1990) Digestion , vol.47 , Issue.1 SUPPL. , pp. 72-75
    • Lundell, L.1
  • 203
    • 0027987155 scopus 로고
    • Omeprazole or ranitidine in long-term treatment of reflux oesophagitis
    • Hallerback B, Unge P, Curling L, et al. Omeprazole or ranitidine in long-term treatment of reflux oesophagitis. Gastroenterology 1994; 107: 1305-11
    • (1994) Gastroenterology , vol.107 , pp. 1305-1311
    • Hallerback, B.1    Unge, P.2    Curling, L.3
  • 204
    • 0028337366 scopus 로고
    • Omeprazole versus ranitidine for prevention of relapse in reflux oesophagitis: A controlled double blind trial of their efficacy and safety
    • Dent J, Yeomans ND, Mackinnon M, et al. Omeprazole versus ranitidine for prevention of relapse in reflux oesophagitis: a controlled double blind trial of their efficacy and safety. Gut 1994; 35: 590-8
    • (1994) Gut , vol.35 , pp. 590-598
    • Dent, J.1    Yeomans, N.D.2    Mackinnon, M.3
  • 205
    • 0029931639 scopus 로고    scopus 로고
    • Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole
    • Robinson M, Lanza F, Avner D, et al. Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole. Ann Intern Med 1996; 124: 859-67
    • (1996) Ann Intern Med , vol.124 , pp. 859-867
    • Robinson, M.1    Lanza, F.2    Avner, D.3
  • 206
    • 0030035185 scopus 로고    scopus 로고
    • Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis
    • Gough AL, Long RG, Cooper BT, et al. Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis. Aliment Pharmacol Ther 1996; 10: 529-39
    • (1996) Aliment Pharmacol Ther , vol.10 , pp. 529-539
    • Gough, A.L.1    Long, R.G.2    Cooper, B.T.3
  • 207
    • 0030947488 scopus 로고    scopus 로고
    • Double blind crossover placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux: The 'sensitive oesophagus'
    • Watson RGP, Tham TCK, Johnston BT, et al. Double blind crossover placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux: the 'sensitive oesophagus'. Gut 1997; 40: 587-90
    • (1997) Gut , vol.40 , pp. 587-590
    • Watson, R.G.P.1    Tham, T.C.K.2    Johnston, B.T.3
  • 208
    • 9344221689 scopus 로고    scopus 로고
    • Reflux symptom relief with omeprazole in patients without unequivocal esophagitis
    • Bate CM, Griffin SM, Keeling PWN, et al. Reflux symptom relief with omeprazole in patients without unequivocal esophagitis. Aliment Pharmacol Ther 1996; 10: 547-55
    • (1996) Aliment Pharmacol Ther , vol.10 , pp. 547-555
    • Bate, C.M.1    Griffin, S.M.2    Keeling, P.W.N.3
  • 209
    • 15444356140 scopus 로고    scopus 로고
    • Heartburn without oesophagitis: Efficacy of omeprazole therapy and features determining therapeutic response
    • Lind T, Havelund T, Carlsson R, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997; 32: 974-9
    • (1997) Scand J Gastroenterol , vol.32 , pp. 974-979
    • Lind, T.1    Havelund, T.2    Carlsson, R.3
  • 210
    • 19244380563 scopus 로고    scopus 로고
    • Gastro-oesophageal reflux disease in primary care: An international study of different treatment strategies with omeprazole
    • Carlsson R, Dent J, Watts R, et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. Eur J Gastro Hepatol 1998; 10: 119-24
    • (1998) Eur J Gastro Hepatol , vol.10 , pp. 119-124
    • Carlsson, R.1    Dent, J.2    Watts, R.3
  • 211
    • 0030801528 scopus 로고    scopus 로고
    • Maintenance treatment for gastro-oesophageal reflux disease: A placebo-controlled evaluation of 10mg omeprazole once daily in general practice
    • Venables TL, Newland RD, Patel AC, et al. Maintenance treatment for gastro-oesophageal reflux disease: a placebo-controlled evaluation of 10mg omeprazole once daily in general practice. Scand J Gastroenterol 1997; 32: 627-32
    • (1997) Scand J Gastroenterol , vol.32 , pp. 627-632
    • Venables, T.L.1    Newland, R.D.2    Patel, A.C.3
  • 212
    • 0030862096 scopus 로고    scopus 로고
    • Omeprazole 10mg once daily, omeprazole 20mg once daily or ranitidine 150mg twice daily, evaluated as initial therapy for the relief of symptoms of gasto-oesophageal reflux disease in general practice
    • Venables TL, Newland RD, Patel AC, et al. Omeprazole 10mg once daily, omeprazole 20mg once daily or ranitidine 150mg twice daily, evaluated as initial therapy for the relief of symptoms of gasto-oesophageal reflux disease in general practice. Scand J Gastroenterol 1997; 32: 965-73
    • (1997) Scand J Gastroenterol , vol.32 , pp. 965-973
    • Venables, T.L.1    Newland, R.D.2    Patel, A.C.3
  • 213
    • 0031917417 scopus 로고    scopus 로고
    • One week omeprazole treatment for the diagnosis of gastro-oesophageal reflux disease
    • Johnsson F, Weywadt L, Salhaug JH. One week omeprazole treatment for the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol 1998; 33: 15-20
    • (1998) Scand J Gastroenterol , vol.33 , pp. 15-20
    • Johnsson, F.1    Weywadt, L.2    Salhaug, J.H.3
  • 214
    • 0027819140 scopus 로고
    • The cost effectiveness of omeprazole and ranitidine in intermittent and maintenance treatment of reflux oesophagitis: The case of Sweden
    • Jonsson B, Stalhammar NO. The cost effectiveness of omeprazole and ranitidine in intermittent and maintenance treatment of reflux oesophagitis: the case of Sweden. Br J Med Econ 1993; 6: 111-26
    • (1993) Br J Med Econ , vol.6 , pp. 111-126
    • Jonsson, B.1    Stalhammar, N.O.2
  • 215
    • 0028662001 scopus 로고
    • Cost effectiveness of omeprazole in the management of gastroesophageal reflux disease in clinical practice
    • Bate CM, Richardson PDI. Cost effectiveness of omeprazole in the management of gastroesophageal reflux disease in clinical practice. Br J Med Econ 1994; 7: 81-97
    • (1994) Br J Med Econ , vol.7 , pp. 81-97
    • Bate, C.M.1    Richardson, P.D.I.2
  • 216
    • 0027818517 scopus 로고
    • Cost effectiveness of 20mg and 40mg of omeprazole in oesophageal reflux disease
    • Bate CM, Richardson PDI. Cost effectiveness of 20mg and 40mg of omeprazole in oesophageal reflux disease. Br J Med Econ 1993; 6: 59-66
    • (1993) Br J Med Econ , vol.6 , pp. 59-66
    • Bate, C.M.1    Richardson, P.D.I.2
  • 217
    • 0029122397 scopus 로고
    • Cost-effectiveness comparison between omeprazole and ranitidine for treatment of reflux oesophagitis
    • Bergmann JF, Humelin B, Barbier JP. Cost-effectiveness comparison between omeprazole and ranitidine for treatment of reflux oesophagitis. Gastroenterol Clin Biol 1995; 19: 482-6
    • (1995) Gastroenterol Clin Biol , vol.19 , pp. 482-486
    • Bergmann, J.F.1    Humelin, B.2    Barbier, J.P.3
  • 218
    • 0029156889 scopus 로고
    • Omeprazole or ranitidine plus metoclopramide for patients with severe erosive oesophagitis: A cost-effectiveness analysis
    • Bloom BS, Hillman AL, La Mont BL, et al. Omeprazole or ranitidine plus metoclopramide for patients with severe erosive oesophagitis: a cost-effectiveness analysis. Pharmacoeconomics 1995; 8: 343-9
    • (1995) Pharmacoeconomics , vol.8 , pp. 343-349
    • Bloom, B.S.1    Hillman, A.L.2    La Mont, B.L.3
  • 219
    • 0028805944 scopus 로고
    • A comparison of the cost-effectiveness of omeprazole and ranitidine in reflux oesophagitis
    • Green JRB, Bate CM, Copeman MB, et al. A comparison of the cost-effectiveness of omeprazole and ranitidine in reflux oesophagitis. Br J Med Econ 1995; 8: 157-69
    • (1995) Br J Med Econ , vol.8 , pp. 157-169
    • Green, J.R.B.1    Bate, C.M.2    Copeman, M.B.3
  • 220
    • 0030864281 scopus 로고    scopus 로고
    • Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrence of erosive reflux oesophagitis: A cost effective analysis
    • Harris RA, Kuppermann M, Richter JE. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrence of erosive reflux oesophagitis: a cost effective analysis. Am J Gastroenterol 1997; 92: 2179-89
    • (1997) Am J Gastroenterol , vol.92 , pp. 2179-2189
    • Harris, R.A.1    Kuppermann, M.2    Richter, J.E.3
  • 221
    • 0024049999 scopus 로고
    • Healing of esophageal ulcer with omeprazole in a patient with Barrett's esophagus and scleroderma
    • Fiorucci S, Santucci L, Bassotti G, et al. Healing of esophageal ulcer with omeprazole in a patient with Barrett's esophagus and scleroderma. Med - Revista della Enciclop Med Ital 1988; 8: 306-9
    • (1988) Med - Revista Della Enciclop Med Ital , vol.8 , pp. 306-309
    • Fiorucci, S.1    Santucci, L.2    Bassotti, G.3
  • 222
    • 0029033187 scopus 로고
    • Long term continuous omeprazole treatment of patients with Barrett's oesophagus
    • Neumann CS, Iqbal TH, Cooper BT. Long term continuous omeprazole treatment of patients with Barrett's oesophagus. Aliment Pharmacol Ther 1995; 9: 451-4
    • (1995) Aliment Pharmacol Ther , vol.9 , pp. 451-454
    • Neumann, C.S.1    Iqbal, T.H.2    Cooper, B.T.3
  • 223
    • 0030947026 scopus 로고    scopus 로고
    • Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus
    • Sharma P, Sampliner RE, Camargo E. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol 1997; 92: 582-5
    • (1997) Am J Gastroenterol , vol.92 , pp. 582-585
    • Sharma, P.1    Sampliner, R.E.2    Camargo, E.3
  • 224
    • 0028054143 scopus 로고
    • Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus
    • Sampliner RE. Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus. Am J Gastroenterol 1994; 89: 1844-8
    • (1994) Am J Gastroenterol , vol.89 , pp. 1844-1848
    • Sampliner, R.E.1
  • 225
    • 0030480397 scopus 로고    scopus 로고
    • Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole
    • Malesci A, Savarino V, Zentilin P, et al. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointest Endosc 1996; 44: 700-5
    • (1996) Gastrointest Endosc , vol.44 , pp. 700-705
    • Malesci, A.1    Savarino, V.2    Zentilin, P.3
  • 226
    • 0027749542 scopus 로고
    • Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy
    • Gore S, Healey CJ, Sutton R, et al. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Pharm Ther 1993; 7: 623-8
    • (1993) Aliment Pharm Ther , vol.7 , pp. 623-628
    • Gore, S.1    Healey, C.J.2    Sutton, R.3
  • 227
    • 0030956504 scopus 로고    scopus 로고
    • Zollinger-Ellison syndrome: Pathogenesis, diagnosis, and management
    • Hirschowitz BI, Maton PN, Freston J, et al. Zollinger-Ellison syndrome: pathogenesis, diagnosis, and management. Am J Gastroenterol 1997; 92 (4 Suppl.): 44S-50S
    • (1997) Am J Gastroenterol , vol.92 , Issue.4 SUPPL.
    • Hirschowitz, B.I.1    Maton, P.N.2    Freston, J.3
  • 228
    • 0030022913 scopus 로고    scopus 로고
    • A prospective study of the effectiveness of low dose omeprazole as initial therapy in Zollinger-Ellison syndrome
    • Termanini B, Gibril F, Stewart CA, et al. A prospective study of the effectiveness of low dose omeprazole as initial therapy in Zollinger-Ellison syndrome. Aliment Pharm Ther 1996; 10: 61-71
    • (1996) Aliment Pharm Ther , vol.10 , pp. 61-71
    • Termanini, B.1    Gibril, F.2    Stewart, C.A.3
  • 229
    • 0030036159 scopus 로고    scopus 로고
    • Long term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h
    • Hirschowitz BI, Mohnen J, Shaw S. Long term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h. Aliment Pharm Ther 1996; 10: 497-506
    • (1996) Aliment Pharm Ther , vol.10 , pp. 497-506
    • Hirschowitz, B.I.1    Mohnen, J.2    Shaw, S.3
  • 230
    • 0030016836 scopus 로고    scopus 로고
    • Long term treatment with lansoprazole for patients with Zollinger-Ellison syndrome
    • Hirschowitz BI, Mohnen J, Shaw S. Long term treatment with lansoprazole for patients with Zollinger-Ellison syndrome. Aliment Pharm Ther 1996; 10: 507-22
    • (1996) Aliment Pharm Ther , vol.10 , pp. 507-522
    • Hirschowitz, B.I.1    Mohnen, J.2    Shaw, S.3
  • 231
    • 0026754286 scopus 로고
    • Symptomatic improvement of gastroduodenal Crohn's disease with omeprazole
    • Woolfson K, Greenberg GR. Symptomatic improvement of gastroduodenal Crohn's disease with omeprazole. Can J Gastroenterol 1992; 6: 21-4
    • (1992) Can J Gastroenterol , vol.6 , pp. 21-24
    • Woolfson, K.1    Greenberg, G.R.2
  • 232
    • 0028221203 scopus 로고
    • Is omeprazole helpful in inflammatory bowel disease?
    • Dickinson JB. Is omeprazole helpful in inflammatory bowel disease? J Clin Gastroenterol 1994 18: 317-9
    • (1994) J Clin Gastroenterol , vol.18 , pp. 317-319
    • Dickinson, J.B.1
  • 233
    • 0028607652 scopus 로고
    • Stress bleeding. Pt 1. Pathogenesis, clinical picture and therapy
    • Tryba M. Stress bleeding. Pt 1. Pathogenesis, clinical picture and therapy. Anaesthetist 1994; 43 (12): 821-34
    • (1994) Anaesthetist , vol.43 , Issue.12 , pp. 821-834
    • Tryba, M.1
  • 234
    • 0023774894 scopus 로고
    • Stress ulceration in medical patients; who, what and how much?
    • Wilcox CM, Spenney JG. Stress ulceration in medical patients; who, what and how much? Am J Gastroenterol 1988; 81 (11): 1199-211
    • (1988) Am J Gastroenterol , vol.81 , Issue.11 , pp. 1199-1211
    • Wilcox, C.M.1    Spenney, J.G.2
  • 235
    • 0028097917 scopus 로고
    • Risk factors for gastrointestinal bleeding in critically ill patients
    • Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 1994; 330 (6): 377-81
    • (1994) N Engl J Med , vol.330 , Issue.6 , pp. 377-381
    • Cook, D.J.1    Fuller, H.D.2    Guyatt, G.H.3
  • 236
    • 0030710213 scopus 로고    scopus 로고
    • Omeprazole, nitrendipine, famotidine and stress induced ulcers
    • Inaloz SS, Gloral V, Sari I, et al. Omeprazole, nitrendipine, famotidine and stress induced ulcers. Acta Gastroenterol Belg 1997; 60 (3): 192-6
    • (1997) Acta Gastroenterol Belg , vol.60 , Issue.3 , pp. 192-196
    • Inaloz, S.S.1    Gloral, V.2    Sari, I.3
  • 237
    • 0027936047 scopus 로고
    • Preventive action of omeprazole, famotidine or nitrendipine against stress ulcer formation in rats
    • Canorac N, Ulak O, Guzel C, et al. Preventive action of omeprazole, famotidine or nitrendipine against stress ulcer formation in rats. Turk J Med Sci 1994; 22(1): 1-5
    • (1994) Turk J Med Sci , vol.22 , Issue.1 , pp. 1-5
    • Canorac, N.1    Ulak, O.2    Guzel, C.3
  • 238
    • 0030859167 scopus 로고    scopus 로고
    • Comparison of omeprazole and ranitidine for stress ulcer prophylaxis
    • Levy MJ, Seelig CB, Robinson NJ, et al. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci 1997; 42(6): 1255-9
    • (1997) Dig Dis Sci , vol.42 , Issue.6 , pp. 1255-1259
    • Levy, M.J.1    Seelig, C.B.2    Robinson, N.J.3
  • 239
    • 0029009463 scopus 로고
    • Inhibitory effects of intravenous lansoprazole on gastric acid hypersecretion in patients with postoperative stress
    • Otani Y, Kitajima M, Sugiyama M, et al. Inhibitory effects of intravenous lansoprazole on gastric acid hypersecretion in patients with postoperative stress. J Clin Gastroenterol 1995; 20 Suppl. 2: S22-S26
    • (1995) J Clin Gastroenterol , vol.20 , Issue.2 SUPPL.
    • Otani, Y.1    Kitajima, M.2    Sugiyama, M.3
  • 240
    • 0030665535 scopus 로고    scopus 로고
    • Current guidelines on stress ulcer prophylaxis
    • Tryba M, Cook D. Current guidelines on stress ulcer prophylaxis. Drugs 1997; 54: 581-96
    • (1997) Drugs , vol.54 , pp. 581-596
    • Tryba, M.1    Cook, D.2
  • 241
    • 0024964987 scopus 로고
    • Therapeutic endoscopy and bleeding ulcers
    • Therapeutic endoscopy and bleeding ulcers. JAMA 1989; 262: 1369-72
    • (1989) JAMA , vol.262 , pp. 1369-1372
  • 242
    • 0026513102 scopus 로고
    • Omeprazole versus placebo for acute upper gastroenterology bleeding. Randomized double blind controlled trial
    • Daneshmend TK, Hawkey CJ, Langman MJ, et al. Omeprazole versus placebo for acute upper gastroenterology bleeding. Randomized double blind controlled trial. BMJ 1992; 304: 143-7
    • (1992) BMJ , vol.304 , pp. 143-147
    • Daneshmend, T.K.1    Hawkey, C.J.2    Langman, M.J.3
  • 243
    • 8244219692 scopus 로고    scopus 로고
    • Effect of omeprazole on the outcome of endoscopically treated bleeding ulcers. Randomized double blind placebo-controlled multi-center study
    • Schaffalitzky OB, Muckadell DE, Havelund T, et al. Effect of omeprazole on the outcome of endoscopically treated bleeding ulcers. Randomized double blind placebo-controlled multi-center study. Scand J Gastroenterol 1997; 32: 320-7
    • (1997) Scand J Gastroenterol , vol.32 , pp. 320-327
    • Schaffalitzky, O.B.1    Muckadell, D.E.2    Havelund, T.3
  • 244
    • 8244245762 scopus 로고    scopus 로고
    • Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding: Results of a placebo-controlled multicenter study
    • Hasselgren G, Lind T, Lundell L, et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding: results of a placebo-controlled multicenter study. Scand J Gastroenterol 1997; 32: 328-33
    • (1997) Scand J Gastroenterol , vol.32 , pp. 328-333
    • Hasselgren, G.1    Lind, T.2    Lundell, L.3
  • 245
    • 0030941533 scopus 로고    scopus 로고
    • A comparison of omeprazole and placebo for bleeding peptic ulcer
    • Khuroo MS, Yattoo GN, Javid G, et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 1997; 336: 1054-88
    • (1997) N Engl J Med , vol.336 , pp. 1054-1088
    • Khuroo, M.S.1    Yattoo, G.N.2    Javid, G.3
  • 246
    • 0024790137 scopus 로고
    • Profound gastric acid inhibition, advantages and potential hazards
    • Festen HMP. Profound gastric acid inhibition, advantages and potential hazards. Scand J Gastroenterol 1989; (171): 99-105
    • (1989) Scand J Gastroenterol , Issue.171 , pp. 99-105
    • Festen, H.M.P.1
  • 247
    • 0026793598 scopus 로고
    • Safety experience from long-term treatment with omeprazole
    • Joelson S, Joelson IB, Lundborg P, et al. Safety experience from long-term treatment with omeprazole. Digestion 1992; 51 Suppl. 1: 93-101
    • (1992) Digestion , vol.51 , Issue.1 SUPPL. , pp. 93-101
    • Joelson, S.1    Joelson, I.B.2    Lundborg, P.3
  • 248
    • 0030036422 scopus 로고    scopus 로고
    • Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole
    • Lewis SJ, Franco S, Young G, et al. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharm Ther 1996; 10: 557-61
    • (1996) Aliment Pharm Ther , vol.10 , pp. 557-561
    • Lewis, S.J.1    Franco, S.2    Young, G.3
  • 249
    • 8944247271 scopus 로고    scopus 로고
    • Bacterial overgrowth during treatment with omeprazole compared with cimetidine: A prospective randomized double blind study
    • Thorens J, Froehlich F, Schwiler W, et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomized double blind study. Gut 1996; 1: 54-9
    • (1996) Gut , vol.1 , pp. 54-59
    • Thorens, J.1    Froehlich, F.2    Schwiler, W.3
  • 250
    • 0030035310 scopus 로고    scopus 로고
    • Candida overgrowth after treatment of duodenal ulcer: A comparison of cimetidine, famotidine and omeprazole
    • Goenka MK, Kochlar R, Chakrabarti A, et al. Candida overgrowth after treatment of duodenal ulcer: a comparison of cimetidine, famotidine and omeprazole. J Clin Gastroenterol 1996; 23: 7-10
    • (1996) J Clin Gastroenterol , vol.23 , pp. 7-10
    • Goenka, M.K.1    Kochlar, R.2    Chakrabarti, A.3
  • 251
    • 0029671070 scopus 로고    scopus 로고
    • Omeprazole as a risk factor for Campylobacter gastroenteritis a case control study
    • Neal KR, Scott HM, Slack RCB, et al. Omeprazole as a risk factor for Campylobacter gastroenteritis a case control study. BMJ 1996; 312 (7028): 414-5
    • (1996) BMJ , vol.312 , Issue.7028 , pp. 414-415
    • Neal, K.R.1    Scott, H.M.2    Slack, R.C.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.